<?xml version="1.0" encoding="UTF-8"?>
<svg height="870.031005859375" width="672.0029907226562" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <path d=" M 0.05999799817800522 826.072021484375 L 22.619997024536133 826.072021484375 L 22.619997024536133 826.35546875 L 0.05999799817800522 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 837.4110107421875 L 33.959449768066406 837.4110107421875 L 33.959449768066406 860.031005859375 L 33.67599868774414 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 837.4110107421875 L 628.2703857421875 837.4110107421875 L 628.2703857421875 860.031005859375 L 627.9869995117188 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 826.072021484375 L 662.0029907226562 826.072021484375 L 662.0029907226562 826.35546875 L 639.3259887695312 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 33.731998443603516 L 662.0029907226562 33.731998443603516 L 662.0029907226562 34.015480041503906 L 639.3259887695312 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 0.0 L 628.2703857421875 0.0 L 628.2703857421875 22.677000045776367 L 627.9869995117188 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 0.0 L 33.959449768066406 0.0 L 33.959449768066406 22.677000045776367 L 33.67599868774414 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 0.05999799817800522 33.731998443603516 L 22.619997024536133 33.731998443603516 L 22.619997024536133 34.015480041503906 L 0.05999799817800522 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <text x="85.039,87.46,92.41,96.328,98.749,103.698,108.648,112.566,117.515,121.038,125.987,129.542,134.025,137.477,140.364,142.785,146.703,149.124,153.042,156.494,160.042,164.991,167.87800000000001,171.38,176.796,183.23399999999998,186.744,191.227,196.177,201.126,204.659,209.608,213.06,218.01,222.493,226.411,231.36,234.875,239.825,242.246,246.729,251.678,254.565,259.515,262.967,266.885,271.834,276.784,280.702,284.154,288.637,291.524,293.945,298.428,302.346,305.909,310.858,318.229,323.644" y="39.74800000000005" svg_rhmargin="330.082" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">included 3 articles of BC and proved high-preoperative dNLR</text>
  <text x="85.039,91.943,96.427,99.879,104.372,108.855,111.276,114.728,119.67699999999999,124.157,127.609,130.03,134.513,139.462" y="50.690000000000055" svg_rhmargin="141.883" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">was also signi</text>
  <text x="141.903" y="50.690000000000055" svg_rhmargin="146.852" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="146.835,150.753,155.237,160.186,163.073,165.494,169.977,174.501,178.984,182.436,185.888,190.837,194.756,197.176,201.66,204.547,208.465,213.41400000000002,217.926,224.83,227.251,230.138,235.08700000000002,239.583,246.487,251.436,254.888,258.34,262.258,266.738,274.108,278.591,283.066,287.549,292.498,297.447,301.944,308.848,313.798,318.281,322.75,325.17" y="50.690000000000055" svg_rhmargin="330.119" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">cantly associated with worse OS and DFS in</text>
  <text x="85.039,89.989,94.472,97.359,99.78,103.698,108.648,111.535,114.987,117.977,124.881,127.302,130.189,135.138,138.159,143.575,150.013" y="61.63099999999997" svg_rhmargin="152.434" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">patients with BC.</text>
  <text x="93.997,100.435,105.384,109.19,113.108,115.529,119.448,123.931,128.414,131.301,135.219,140.168,143.998,151.368,156.784,163.222,165.643,170.592,177.963,183.378,189.81599999999997,193.66,196.081,201.03,205.98,208.4,212.319,216.802,219.689,223.607,228.556,232.38,235.267,240.216,244.13400000000001,247.913,252.863,256.781,261.73,264.617,268.069,273.019,277.968,282.918,285.339,287.759,290.647,295.596,299.514,304.464,308.382,313.331,318.281,322.199,327.148" y="72.62900000000002" svg_rhmargin="330.035" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">An elevated NLR/dNLR indicated the neutrophil-dependent</text>
  <text x="85.039,87.46" y="83.57100000000003" svg_rhmargin="92.409" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">in</text>
  <text x="92.41" y="83.57100000000003" svg_rhmargin="97.359" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="97.342,101.825,109.195,116.566,121.049,123.936,128.885,132.338,136.821,139.747,143.199,147.118,151.601,155.519,158.406,160.827,165.776,170.72500000000002,173.649,180.553,185.036,188.488,191.45,193.871,198.82,202.738,206.19,210.109,214.592,218.044,221.962,226.911,229.332,232.267,237.216,242.166,245.053,247.914,250.335,254.818,262.188,267.138,272.087,277.037,280.955,285.438,288.325,292.243,295.131,302.501,306.419,311.369,313.789,318.273,321.16,325.078" y="83.57100000000003" svg_rhmargin="330.027" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ammatory reaction was increased, but lymphocyte-mediated</text>
  <text x="85.039,89.523,94.472,97.359,99.78,102.667,107.617,114.987,119.936,123.388,126.367,128.788,136.158,143.528,148.478,153.427,157.345,160.268,163.72,167.639,171.091,176.04,180.99,185.939,189.391,193.309,196.267,203.171,207.654,211.106,214.012,216.432,221.382,228.286,232.204,235.656,238.077,241.053,246.935,251.884,255.803,259.255,263.173,266.11,271.06,275.543,280.026,283.944,286.859,290.777,295.261,297.682,302.631,306.549,311.499,315.417,319.335,322.291,325.178" y="94.51300000000003" svg_rhmargin="330.127" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">antitumor immune response was lower. There have evidence to</text>
  <text x="85.039,89.989,93.907,101.277,106.227,111.176,114.628,117.515,120.967,125.45,128.338,132.256,137.025,139.912,144.862,152.232,157.181,160.633,165.371,169.854,173.306,176.758,181.708,185.626,188.047,192.53,195.417,199.336,204.28500000000003,209.024,213.973,217.891,222.841,225.728,229.18,234.129,239.079,244.028,246.449,248.87,252.322,257.041,260.493,265.442,270.392,275.341,280.29,283.743,286.63,291.339,298.709,302.627,305.514,309.998,313.45,316.337,320.82,323.707,326.128" y="105.51099999999997" svg_rhmargin="330.046" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">demonstrate tumor associated neutrophils support metastatic</text>
  <text x="85.039,87.46,92.41,94.831,97.718,100.139,104.622,107.509,109.93,114.879,119.828,122.398,127.348,130.23499999999999,132.716,138.132,144.569" y="116.452" svg_rhmargin="146.99" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">initiation of BC.</text>
  <text svg_rhmargin="168.077" x="147.005,149.171,152.883,156.596,158.412,162.2,165.912,168.077" y="116.45399999999995" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:5.98px;font-style:NORMAL;font-weight:normal;">[44,45] </text>
  <text x="170.589,177.959,181.877,186.827,189.714,193.166,198.115,203.065,208.014,210.435,212.856,215.743,220.693,224.611,228.063,230.484,234.967,238.885,243.834,246.385,248.806,252.724,257.673,262.623,267.572,270.459,273.911,276.332,280.25,285.2,289.118,292.57,295.139,299.622,302.043,306.992,310.911,315.86,318.326,321.213,326.162" y="116.45399999999995" svg_rhmargin="330.08" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Neutrophil-derived leukotrienes aided the</text>
  <text x="85.039,88.957,93.906,96.327,101.277,106.226,108.647,112.565,117.048,119.936,122.356,127.306,132.255,137.988,142.938,145.825,151.537,156.487,158.908,162.36,165.247,169.73,174.679,177.566,183.228,186.115,188.536,191.988,195.44,200.389,204.308,207.76,213.501,218.45,222.933,228.638,232.09,236.008,238.429,242.347,246.265,249.152,251.573,256.057,259.975,262.396,266.879,272.573,276.492,281.441,286.39,290.874,295.823,300.772,303.193,308.143,312.626,318.323,321.21,326.16" y="127.39499999999998" svg_rhmargin="330.078" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">colonization of distant tissues by selectively expanding the</text>
  <text x="85.039,88.491,93.44,98.39,103.339,108.288,113.238,115.659,119.337,124.286,127.173,130.901,134.82,139.303,144.252,148.17,152.089,155.541,159.247,163.165,167.083,169.504,171.925,175.377,179.089,181.976,186.925,191.409,194.296,198.024,201.476,205.394,208.281,212.765,215.185,220.13400000000001,223.818,228.768,231.189,235.672,240.621,244.34,247.227,252.177,259.547,264.497,267.949,270.369,274.853,278.771,283.72,286.141,290.059,293.775,298.724,303.674,306.561,310.479,315.429,318.316,320.737,325.22,327.641" y="138.39300000000003" svg_rhmargin="330.062" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">subpool of cancer cells that retain high tumorigenic potential.</text>
  <text x="85.039,87.926,92.875,97.825,100.246,105.195,107.616,110.503,112.924,117.873,122.822,125.46,130.409,133.296,135.948,138.835,143.784,147.702,150.347,152.768,156.687,161.636,166.585,171.535,174.422,177.874,180.295,184.213,189.163,193.081,195.968,200.451,204.369,209.319,213.237,216.689,221.172,224.059,226.48,231.43,235.913,238.558,242.476,247.426,251.344,255.827,263.197,267.115,269.795,274.278,277.73,282.213,286.131,291.081,293.502,298.451,303.4,308.35,312.833,315.72,319.63800000000003,322.291,327.24" y="149.33500000000004" svg_rhmargin="330.127" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Inhibition of the leukotriene-generating enzyme arachidonate 5-</text>
  <text x="85.039,87.46,89.881,94.83,99.779,104.729,109.212,113.695,117.613,122.563,127.046,130.498,134.416,136.344,143.714,148.197,152.68,154.598,159.082,164.031,167.483,172.432,176.916,181.399,184.286,188.204,190.143,195.093,198.545,203.494,206.381,213.752,217.67,220.557,225.04,228.492,231.38,235.863,238.75,241.171,245.089,247.061,251.544,255.462,258.349,260.77,265.253,267.674,270.561,275.044,276.994,281.943,284.83,286.801,291.751,295.669,300.618,303.505,306.957,311.907,316.856,321.806,324.227,326.647" y="160.27599999999995" svg_rhmargin="330.099" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">lipoxygenase may abrogate pro-metastatic activity of neutrophils</text>
  <text x="85.039,89.522,94.471,99.42,106.355,109.807,113.726,118.675,123.624,127.543,131.461,138.443,140.864,145.813,150.763,155.246,162.196,169.567,173.485,176.372,180.855,184.307,187.194,191.678,195.13,197.551,201.003" y="171.21799999999996" svg_rhmargin="203.424" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">and reduce lung metastasis.</text>
  <text svg_rhmargin="215.227" x="203.471,205.637,209.349,213.062,215.227" y="171.21900000000005" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:5.98px;font-style:NORMAL;font-weight:normal;">[45] </text>
  <text x="222.236,228.674,233.623,236.511,238.931,242.85,247.333,252.282,256.201,260.119,263.571,270.537,275.486,278.938,283.888,288.371,291.823,298.769,301.656,304.077,306.498,310.416,312.837,315.258,322.296,327.245" y="171.21900000000005" svg_rhmargin="330.132" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Anticancer drugs (i.e., 5-</text>
  <text x="85.039" y="182.21699999999998" svg_rhmargin="89.988" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="89.972,94.921,99.87,103.322,108.272,113.221,116.673,121.156,125.075,127.496,129.916,132.803,137.649,145.019,148.938,153.887,156.308,160.791,163.678,167.596,172.54500000000002,177.389,181.873,186.356,190.839,194.291,198.774,203.257,207.74,210.628,213.048,217.998,222.947,227.731,232.68,235.567,240.373,245.789,252.22699999999998,257.041,264.411,268.329,271.216,275.7,279.152,282.039,286.522,289.974,292.395,295.847,300.693,303.58,308.529,313.279,315.7,320.649,325.599" y="182.21699999999998" svg_rhmargin="330.082" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">uorouracil) mediated aggravation of BC metastasis to lung</text>
  <text x="85.039,91.943,96.426,99.878,105.505,109.988,112.409,115.861,120.81,126.424,130.907,133.794,136.682,140.134,142.554,147.504,152.453,155.34,159.259,164.208,169.85,172.737,177.686,183.286,185.707,190.656,194.574,198.026,201.945,206.428,209.88,213.798,218.747,224.387,226.808,231.758,234.645,238.097,242.58,247.529,252.479,254.9,262.27,267.219,272.169,276.652,280.104,284.587,290.262,295.211,299.129,304.079,306.966,310.418,315.367,320.317,325.266,327.687" y="193.159" svg_rhmargin="330.108" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">was also attributed to increased intrapulmonary neutrophil</text>
  <text x="85.039,89.989,94.938,102.308,107.258,111.176,114.628,118.08,123.079,127.562,132.511,137.46,142.411,146.329,151.279,156.228,159.68,163.598,167.05,170.502,172.923,177.873,182.822,187.821,192.77,195.657,200.634,205.583,209.501,214.451,217.338,220.79,225.739,230.689,235.638,238.059,240.48,242.901,246.81900000000002,251.826,255.744,260.694,264.612,271.982,276.932,281.881,284.302,289.251,293.17,296.622,301.657,304.544,310.982,313.869,320.773,323.66" y="204.10000000000002" svg_rhmargin="330.098" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">numbers and expression of neutrophilic chemokines (C-X-C</text>
  <text x="85.039,92.41,97.359,100.246,102.667,105.554,108.112,112.031,116.98,120.898,128.268,133.218,138.167,140.588,145.538,149.45600000000002,151.991,154.412,156.832,161.316,165.799,170.748,175.697,178.182,183.131,185.552,188.047,194.485,199.434,203.352,205.773,210.722,213.274,217.758,222.707,227.656,230.169,236.607,241.556,245.474,247.895,252.844,255.731,258.231,260.651,265.6,268.152,271.039,275.988,283.359,288.308,291.76,294.287,298.205,302.123,304.544,306.965,310.417,312.83799999999997,315.375,321.257,326.207" y="215.09799999999996" svg_rhmargin="330.125" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">motif chemokine ligand 1, Cxcl1 and Cxcl2) in tumor cells. The</text>
  <text x="85.039,89.522,94.472,101.842,104.263,109.212,111.633,115.085,117.972,121.424,125.908,128.795,131.216,136.165,141.114,144.905,149.854,152.741,156.527,161.01,164.803,169.753,173.671,178.621,181.508,184.96,189.909,194.859,199.808,202.229,204.65,207.537,212.486,216.405,221.354,223.775,227.693,230.58,233.001,237.951,242.434,246.269,250.752,255.701,258.588,261.009,265.959,270.908,275.857,280.34000000000003,284.081,289.031,292.483,296.27,300.753,304.547,310.985,313.872,320.776,323.663" y="226.03999999999996" svg_rhmargin="330.101" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">administration of a neutrophil-depleting antibody or a C-X-C</text>
  <text x="85.039,92.41,97.359,100.246,102.667,105.554,111.06,114.979,119.928,123.846,131.217,136.166,141.115,143.536,148.486,152.404,157.887,161.339,165.257,169.175,173.094,178.043,180.93,185.88,189.332,194.85,199.799,205.224,208.112,214.549,219.499,223.417,226.869,231.819,234.706,240.203,244.686,249.635,252.523,257.006,261.489,266.438,271.388,273.809,277.261,280.148,282.569,288.107,292.59,298.006,302.955,307.905,312.854,317.804,322.753,327.702" y="236.98199999999997" svg_rhmargin="330.123" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">motif chemokine receptor 2 (Cxcr2) antagonist, SB225002,</text>
  <text x="85.039,88.491,90.912,95.395,100.345" y="247.98000000000002" svg_rhmargin="102.766" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">signi</text>
  <text x="102.784" y="247.98000000000002" svg_rhmargin="107.733" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="107.717,111.635,116.118,121.068,123.955,126.376,130.859,134.758,139.241,142.129,145.016,148.934,153.883,158.833,163.316,166.203,170.121,175.07000000000002,178.977,183.927" y="247.98000000000002" svg_rhmargin="186.814" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">cantly attenuated 5-</text>
  <text x="186.804" y="247.98000000000002" svg_rhmargin="191.753" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="191.736,196.686,201.635,205.087,210.037,214.986,218.438,222.921,226.84,229.26,231.681,234.568,241.939,245.857,250.806,253.227,257.71,260.598,264.516,269.46500000000003,273.428,277.346,282.295,287.245,291.728,296.677,300.595,304.514,309.463,313.281,315.702,320.651,325.601" y="247.98000000000002" svg_rhmargin="330.084" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">uorouracil-mediated enhanced lung</text>
  <text x="85.04,92.41,96.329,99.216,103.699,107.151,110.038,114.521,117.973,120.394,123.846" y="258.92100000000005" svg_rhmargin="126.267" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">metastasis.</text>
  <text svg_rhmargin="138.068" x="126.312,128.478,132.19,135.903,138.06799999999998" y="258.923" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:5.98px;font-style:NORMAL;font-weight:normal;">[46] </text>
  <text x="142.753,149.657,154.606,159.556,164.039,166.926,169.34699999999998,173.99,177.908,180.795,185.441,189.924" y="258.923" svg_rhmargin="192.345" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Donati et al</text>
  <text svg_rhmargin="204.115" x="192.359,194.525,198.238,201.95,204.11499999999998" y="258.923" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:5.98px;font-style:NORMAL;font-weight:normal;">[47] </text>
  <text x="208.743,213.226,215.647,219.099,224.048,228.699,232.151,236.069,241.018,245.968,249.42,252.307,256.225,261.17400000000004,265.832,270.781,274.699,279.649,282.536,285.988,290.937,295.887,300.836,303.257,305.678,309.13,313.793,321.163,325.646" y="258.923" svg_rhmargin="330.129" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">also reported neutrophils may</text>
  <text x="85.039,89.988,93.44,98.39,105.76,110.709,113.596,117.51400000000001,119.507,123.99,128.94,133.889,137.807,141.259,143.68,148.163,152.082,157.031,160.949,164.401,167.853,170.274,172.286,174.707,179.657,184.14,188.623,192.075,194.496,198.979,202.897,207.847,211.765,215.217,218.669,221.09,223.081,227.564,232.514,237.46300000000002,239.465,246.836,249.257,253.74,257.192,261.675,264.562,266.983,271.932,276.88100000000003,278.866,283.815,286.702,288.731,294.146,300.584,302.564,306.482,310.401,312.821,315.242,318.694,320.706,325.655" y="269.865" svg_rhmargin="330.138" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">promote adhesiveness, invasiveness, and migration of BC cells by</text>
  <text x="85.039,88.491,92.409,96.327,99.779,103.698,106.585,109.006,113.955,118.438,125.8,129.718,134.201,137.088,142.038,146.987,149.408,154.357,158.275,165.654,168.075,173.024,175.911,179.83,183.282,185.703,189.621,194.57,199.52,201.941,206.89,209.777,214.727,219.676,222.09699999999998,229.488,236.392,241.341,243.762,246.183,250.101,257.437,259.858,264.807,268.259,271.146,273.567,275.988,278.409,282.892,285.779,288.2,293.149,298.098,305.51,310.46,313.347,320.647,325.13" y="280.86300000000006" svg_rhmargin="330.079" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">secreting cytokine interleukin-16, while instillation of an</text>
  <text x="85.039,87.46,92.409,95.296,99.215,102.667,105.087,109.006,113.955,118.905,121.325,126.275,129.162,134.111,139.06,145.188,150.138,154.056,159.005,161.893,165.345,169.828,172.249,174.67,178.588,181.009,185.958,190.441,196.55,201.033,205.983,208.87,211.291,216.24,221.189,226.139,230.622,236.744,240.196,244.114,248.598,252.516,255.968,259.42,263.338,268.28700000000003,274.387,277.275,282.224,286.142,292.246,296.164,299.051,301.938,305.856,309.775,312.662,316.114,322.235,327.185" y="291.804" svg_rhmargin="330.072" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">interleukin-16 neutralizing antibody reversed the effects of</text>
  <text x="85.039,89.988,93.907,98.856,101.743,105.195,110.144,115.094,120.043,122.464,124.885,128.337,130.75799999999998,138.612,144.027,148.51,152.429,157.378,159.79899999999998,167.637,174.075,179.024,181.912,184.799,188.717,191.138,194.025,201.879,205.797,208.684,216.505,220.989" y="302.746" svg_rhmargin="223.41" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">neutrophils. Even, Coffelt et al</text>
  <text svg_rhmargin="235.183" x="223.427,225.593,229.305,233.018,235.183" y="302.747" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:5.98px;font-style:NORMAL;font-weight:normal;">[48] </text>
  <text x="243.042,245.93,250.879,255.828,260.778,265.72700000000003,273.542,276.429,281.379,288.749,293.699,297.151,300.038,302.459,307.408,312.357,317.307,321.225,325.143" y="302.747" svg_rhmargin="330.092" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">found tumor-induced</text>
  <text x="85.038,89.988,93.906,98.855,101.743,105.195,110.144,115.093,120.043,122.464,124.885,128.33700000000002,131.921,139.292,143.775,148.258,151.764,156.713,160.165,165.115,172.485,177.434,180.321,184.239,187.819,190.706,195.656,199.574,203.125,207.044,210.496,213.383,217.866,222.815,225.236,227.657,231.109,236.059,243.429,247.347,252.297,255.184,258.795,263.745,266.632,270.191,275.14,280.089,282.51,289.881,294.83,299.779,304.263,307.715,312.198,315.714,320.197,325.146" y="313.688" svg_rhmargin="330.095" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">neutrophils may promote the establishment of pulmonary and</text>
  <text x="85.038,87.459,91.942,99.313,104.262,109.211,111.57,116.519,121.468,126.418,130.336,132.658,140.029,143.947,146.834,151.317,154.769,157.656,162.14,165.592,169.51,172.962,175.347,180.296,184.779,187.139,190.591,195.54,200.489,205.439,208.891,212.809,216.261,219.713,222.134,227.083,231.566,233.909,237.827,242.31,245.197,250.147,253.034,257.983,262.932,265.353,269.271,271.665,277.547,279.885,282.306,286.789,294.159,299.109,304.058,309.008,312.926,317.409,320.296,324.214,327.666" y="324.686" svg_rhmargin="330.087" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">lymph node metastases by suppressing cytotoxic T lymphocytes.</text>
  <text x="85.038,90.454,96.892,101.252,106.202,110.685,113.572,115.993,119.911,124.86,127.748,131.20000000000002,135.55,142.454,144.875,147.762,152.711,157.092,164.463,168.381,171.268,175.751,179.203,182.09,186.574,190.026,193.944,197.396,201.822,206.305,209.757,213.675,218.035,225.406,230.355,233.807,237.725,242.072,247.022,250.474,255.423,260.373,264.291,268.661,271.548,276.497,280.85,285.799,290.282,294.766,298.684,303.016,306.468,311.418,316.367,319.819,322.706,326.625" y="335.628" svg_rhmargin="330.077" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">BC patients with metastases are more prone to have shorter</text>
  <text x="85.038,88.49,93.44,96.892,101.375,103.796,108.279,112.762,115.183,117.466,120.353,122.774,130.144,134.062,136.483,138.781,141.669,146.61800000000002,148.873,151.294,153.715,158.664,162.582,164.86,171.764,174.185,177.072,182.02100000000002,184.305,187.192,192.142,196.06,199.512,203.43,205.735,209.187,212.074,217.023,221.973,224.393,228.312,231.764,234.185,236.461,243.365,247.28300000000002,249.557,254.041,256.461,259.913,264.862,267.132,270.019,274.969,279.918,284.868,289.817,292.077,294.964,299.913,303.831,306.079,313.548,319.986,322.293,327.242" y="346.569" svg_rhmargin="330.129" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">survival time. In line with these studies, we also found the HR of</text>
  <text x="85.038,92.409,97.824,104.262,106.411,109.298,114.248,117.7,119.791,124.74,129.69,134.639,138.091,140.2,147.57,152.053,154.146,161.05,165.533,168.98499999999999,171.153,176.103,178.524,183.007,187.956,191.875,195.327,197.401,199.822,204.77100000000002,206.925,210.377,213.265,218.214,223.163,225.584,229.503,232.95499999999998,235.101,242.005,244.426,247.313,252.262,254.376,261.746,264.167,269.117,273.035,277.98400000000004,280.114,283.566,286.453,290.936,295.419,299.337,301.429,304.316,309.266,313.749,318.232,320.653,325.602" y="357.568" svg_rhmargin="330.085" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">NLR for poor OS was higher in studies with mixed stage (having</text>
  <text x="85.038,92.409,96.327,99.214,103.697,107.149,110.036,114.52,117.407,119.828,123.74600000000001,126.763,130.681,135.164,138.616,142.535,145.987,148.874,151.877,154.764,159.713,164.196,169.145,172.172,175.059,180.008,183.92600000000002,186.912,190.83,195.313,198.765,201.186,205.669,208.681,212.133,215.02,219.503,223.986,227.905" y="368.509" svg_rhmargin="230.326" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">metastatic cases) than the early stage.</text>
  <text x="93.996,99.878,104.827,108.745,112.197,116.11500000000001,117.92,122.403,125.855,129.773,131.639,135.091,139.009,143.492,147.411,150.863,155.346,157.767,159.588,162.009,164.43,171.8,174.221,177.108,181.591,184.478,186.899,191.849,196.798,200.25,202.106,204.527,209.476,211.29,214.177,219.127,221.548,225.0,226.823,234.194,238.112,240.999,245.482,248.369,252.853,257.802,262.285,264.706,269.189,272.641,275.062,278.514,280.935,282.777,287.726,290.147,293.599,297.051,299.938,302.359,306.842,309.263,311.122,315.605,318.026,320.447,322.29,327.24" y="379.451" svg_rhmargin="330.127" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">There are several limitations in this meta-analysis. Firstly, all of</text>
  <text x="85.038,88.957,93.906,97.358,102.307,104.728,107.149,111.068,116.017,120.527,123.979,126.866,131.816,136.765,139.186,143.104,146.556,151.083,157.987,161.906,165.358,169.276,173.76,177.212,181.13,184.017,187.469,192.419,195.871,200.82,204.738,208.657,211.544,213.965,218.448,222.366,224.787,229.317,236.221,241.17,243.591,247.51,252.459,256.982,264.353,268.836,273.319,277.788,280.209,284.127,288.61,293.559,298.084,300.971,305.92,310.387,313.839,318.788,326.158" y="390.449" svg_rhmargin="330.076" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">enrolled studies were retrospective, which may lead to some</text>
  <text x="85.038,89.988,92.409,96.892,100.344,104.262,107.714,110.135,113.894,118.377,122.295,126.213,131.163,136.112,141.062,143.482,147.966,150.387,154.144,159.094,164.043,166.464,170.947,174.724,179.673,183.454,186.906,189.793,194.743,199.692,202.113,206.031,209.483,213.217,220.121,224.039,227.491,231.40900000000002,235.213,237.634,242.583,246.502,248.923,253.872,258.821,262.74,267.689,271.439,274.326,279.27500000000003,283.004,286.923,291.406,295.889,298.31,303.259,307.742,310.63,314.548,318.323,321.21,326.159" y="401.39" svg_rhmargin="330.077" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">biases. Secondly, only 3 studies were included to evaluate the</text>
  <text x="85.038,89.988,93.44,98.389,102.872,107.822,112.771,116.223,119.11,121.531,125.44900000000001,127.896,131.348,133.769,138.252,143.202" y="412.332" svg_rhmargin="145.623" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">prognostic signi</text>
  <text x="145.643" y="412.332" svg_rhmargin="150.592" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="150.576,154.494,158.977,163.927,167.845,171.763,174.159,179.108,181.995,184.42,189.369,196.74,202.155,208.593,211.065,213.952,218.902,222.35399999999998,224.728,228.18,233.129,236.581,241.065,243.485,247.969,252.452,254.873,257.294,259.763,266.667,271.616,274.037,277.956,282.90500000000003,285.33,292.701,297.184,301.66700000000003,304.095,306.516,310.434,314.917,319.866,322.293,325.18" y="412.332" svg_rhmargin="330.129" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">cance of dNLR for survival, which may lead to</text>
  <text x="85.038,87.925,92.875,96.793,98.985,103.934,108.417,112.335,115.787,119.706,123.158,126.045,128.466,135.836,140.319,143.206,145.627,150.577,155.526,157.716,162.666,166.118,168.318,173.268,178.217,183.166,187.085,190.537,194.455,197.907,200.794,203.215,210.585,215.069,217.956,220.377,225.326,230.275,232.435,237.385,240.272,242.47,244.89,247.778,251.23,253.411,257.894,262.377,264.798,269.748,273.666,276.087,278.242,284.123,289.073,291.494,294.946,299.895,302.316,306.799,309.21999999999997,311.463,318.833,323.782,327.234" y="423.274" svg_rhmargin="330.121" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">the overestimation or underestimation of its value. Thirdly, most</text>
  <text x="85.038,89.988,92.875,98.361,101.813,104.701,109.65,114.599,117.02,120.939,124.39099999999999,129.825,132.246,137.195,141.114,143.534,148.484,153.433,157.352,162.30100000000002,167.808,172.757,176.676,181.625,184.512,188.995,193.945,196.366,201.315,205.798,210.281,215.231,218.118,223.592,228.075,233.024,237.974,240.395,245.344,248.796,254.262,258.745,263.695,266.116,271.065,275.548,280.031,284.981,287.868,293.322,296.209,299.661,303.579,308.063,310.95,318.32,322.238,327.188" y="434.272" svg_rhmargin="330.075" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">of studies included neo-adjuvant and/or adjuvant treatment</text>
  <text x="85.038,89.988,93.44,98.389,101.276,106.226,110.144,115.093,117.514,120.966,122.795,127.278,132.227,137.17600000000002,138.952,141.839,146.788,150.70600000000002,152.501,155.953,160.902,164.354,168.837,171.258,175.741,180.225,182.646,184.475,189.424,194.373,197.261,201.179,206.128,213.499,217.417,220.869,222.685,230.055,234.538,239.02100000000002,240.826,245.775,249.693,251.484,253.905" y="445.213" svg_rhmargin="258.854" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">protocols and the survival outcomes may be in</text>
  <text x="258.859" y="445.213" svg_rhmargin="263.808" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="263.791,268.741,272.659,277.608,281.527,285.445,290.394,292.815,294.631,299.58,304.53,309.479,312.931,315.818,320.768,323.189,327.672" y="445.213" svg_rhmargin="330.093" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">uenced. Fourthly,</text>
  <text x="85.038,87.926,92.875,96.793,99.608,103.526,108.475,111.363,114.25,119.199,122.086,124.973,127.84,132.323,136.806,139.227,144.176,148.094,150.97,153.857,158.807,162.259,165.087,167.974,172.923,176.841,179.714,187.084,192.499,198.93699999999998,201.766,206.716,209.136,212.024,214.911,218.829,222.281,226.199,231.14800000000002,234.023,236.444,241.393,244.228,248.146,252.629,256.548,261.497,264.296,267.748,270.635,275.585,280.534,285.017,287.879,292.363,294.783,297.671,302.62,307.569,312.519,317.002,321.951,324.786,327.207" y="456.155" svg_rhmargin="330.094" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">the cut-off value for the NLR differed in each study although it</text>
  <text x="85.038,91.942,96.426,99.878,103.576,108.526,113.475,116.362,121.31099999999999,124.949,128.401,130.822,135.305,140.255" y="467.153" svg_rhmargin="142.676" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">was both signi</text>
  <text x="142.695" y="467.153" svg_rhmargin="147.644" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="147.684,151.602,156.086,161.035,163.922,167.583,172.066,175.984,179.903,184.852,188.304,193.254,195.674,200.624,205.107,208.798,211.685,216.63400000000001,220.306,225.255,230.205,233.657,237.313,240.765,245.715,250.664,255.147,258.599,263.548,268.498,273.447,277.11,281.593,286.543,291.026,293.447,297.93,301.382,303.803,307.255,309.676,313.392,319.274,324.223,326.644" y="467.153" svg_rhmargin="330.096" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">cant according to our subgroup analysis. This</text>
  <text x="85.038,92.409,96.892,101.375,104.371,106.791" y="478.094" svg_rhmargin="111.74" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">may in</text>
  <text x="111.741" y="478.094" svg_rhmargin="116.69" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="116.673,121.623,125.541,130.49,134.409,138.327,141.334,144.221,149.171,153.089,155.51,158.962,161.97,165.888,168.309,170.73,175.68,178.1,182.019,186.502,188.923,191.96,196.443,201.392,206.342,208.763,211.183,215.102,219.585,222.472,224.893,229.842,234.792" y="478.094" svg_rhmargin="237.213" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">uence their clinical application.</text>
  <text x="93.996,96.883,101.832,106.014,109.932,114.882,119.831,123.749,126.17,131.12,134.572,136.993,141.942,146.891,149.31199999999998,153.578,156.465,161.414,163.835,167.287,171.492,178.863,182.781,185.668,190.151,193.038,197.521,202.471,206.954,209.375,213.858,217.31,219.731,223.183,227.389,232.339,236.257,243.627,248.577,253.526,256.978,259.865,263.317,267.8,270.687,274.606,278.058,282.323,287.272,290.724,294.643,299.592,304.541,308.46,311.912,316.395,319.282,321.703,326.186" y="489.036" svg_rhmargin="330.104" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">In conclusion, this meta-analysis demonstrates preoperative</text>
  <text x="85.038,92.409,97.824,104.262,106.683,111.632,119.003,124.418,130.856,132.829,140.199,144.682,149.165,151.083,156.033,159.951,161.911,165.829,168.716,171.603,175.522,179.44,182.327,184.748,189.231,193.149,195.132,200.081,203.533,207.452,212.401,214.822,218.74,221.627,224.048,228.531,232.449,234.419,239.368,241.789,246.738,254.109,258.592,262.044,266.993,270.912,274.364,277.816,279.828,282.715,287.664,291.116,293.037,297.986,301.438,306.388,310.871,315.82,320.77,324.222,326.643" y="500.034" svg_rhmargin="330.095" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">NLR/dNLR may be effective predictive biomarkers for prognosis</text>
  <text x="85.038,87.459,92.408,95.016,99.965,104.449,107.336,109.757,113.675,118.624,121.511,124.963,127.613,134.517,136.938,139.825,144.774,147.455,152.871,159.309,161.73,164.35,171.254,175.172,178.059,181.977,185.896,188.783,191.204,196.153,201.102,203.75,208.7,211.587,214.238,221.609,227.024,233.462,235.883,240.832,248.203,253.618,260.056,262.653,270.023,274.506,278.989,281.644,286.594,290.512,293.152,298.102,302.02,304.441,309.39,312.278,317.227,319.64799999999997,322.292,325.179" y="510.976" svg_rhmargin="330.128" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">in patients with BC. Detection of NLR/dNLR may be helpful to</text>
  <text x="85.038,87.459,92.409,96.327,101.276,104.163,106.584,109.471,113.95400000000001,116.956,119.843,124.792,128.71,131.752,136.701,141.184,144.072,146.492,150.411,155.36,158.247,161.699,164.69,171.594,176.543,181.49200000000002,184.475,189.424,193.342,198.292" y="521.9169999999999" svg_rhmargin="202.21" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">identify the patients who bene</text>
  <text x="202.223" y="521.9169999999999" svg_rhmargin="207.172" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="207.156,210.043,213.052,215.939,219.391,224.341,231.711,234.708,237.595,242.545,246.463,249.505,252.957,257.906,261.358,265.841,269.759,273.211,277.695" y="521.9169999999999" svg_rhmargin="280.116" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">t from the surgery.</text>
  <text x="85.039,91.636,97.552,101.195,107.111,112.827,116.764,119.905,125.423,131.14,137.055,140.699,144.636,147.39,153.306,159.221,162.865,165.619,171.336,177.251" y="549.587" svg_rhmargin="182.475" style="fill:#171615;font-family:MMHCLG+AdvOTfbba3ace.B;font-size:9.46px;font-style:NORMAL;font-weight:normal;">Author contributions</text>
  <text x="85.039,88.491,97.458,104.362,106.129,110.612,115.562,120.511,122.286,131.253,137.69099999999997,139.464,144.413,148.896,152.349,155.236,157.657,161.575,163.996,168.945,173.428,176.315,180.234,185.18300000000002,186.971,189.392,194.341,196.155,200.073,205.023,209.972,213.891,217.809,222.758,225.645,228.066,233.016,237.965,239.75,244.233,249.183,254.132,255.908,260.857,264.775,268.227,270.648,275.131,280.08,281.872,286.822,289.709,291.453,294.34,299.289,301.71,305.162,306.929,310.381,313.269,318.218,323.167,327.651" y="565.518" svg_rhmargin="330.072" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">JWD and MY participated in conception and design of this study.</text>
  <text x="85.039,88.491,97.458,104.362,108.51,112.993,117.942,122.89099999999999,127.047,132.463,137.879,142.828,146.946,151.896,155.814,159.266,162.153,167.103,170.555,177.925,181.843,186.792,190.995,195.478,199.397,204.346,209.295,211.716,215.168,217.589,220.476,222.897,227.847,232.79600000000002,236.972,241.921,244.808,248.934,253.883,258.366,261.253,265.736,268.157,272.347,275.799,284.766,291.67,295.817,300.301,305.25,310.199,314.355,319.771,325.187" y="576.46" svg_rhmargin="330.136" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">JWD and LLP performed acquisition of data; JWD and LLP</text>
  <text x="85.039,89.989,93.907,97.359,100.246,105.196,108.648,116.018,119.936,124.885,132.546,135.434,140.383,144.30100000000002,151.935,155.387,158.274,162.757,165.645,168.066,171.518,174.405,176.826,180.744,185.227,187.648,195.304,199.787,204.737,209.22,211.641,216.124,219.576,223.494,226.946,229.367,237.029,245.995,252.433,260.046,266.95,271.434,274.886,282.496,284.917,289.866,294.35,299.299,301.72,306.203,310.121,315.07,322.747,325.168" y="587.458" svg_rhmargin="330.117" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">performed the statistical analyses; MY was involved in</text>
  <text x="85.039,87.46,92.41,95.297,99.215,102.667,107.617,111.069,114.987,117.874,122.357,125.244,127.665,132.615,137.56400000000002,140.03,144.979,147.866,150.347,155.297,159.78,162.667,167.15,169.571,172.004,175.456,184.422,191.326,193.773,198.722,202.174,206.657,209.545,212.432,216.35,221.299,223.762,226.65,231.599,235.517,237.935,245.306,249.789,254.738,259.688,263.14,267.058,270.51,272.931,277.88,280.767,283.188,285.669,294.636,301.074,303.528,306.98,310.898,315.381,317.802,321.254,325.172" y="598.399" svg_rhmargin="330.121" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">interpretation of data. JWD drafted the manuscript. MY revised</text>
  <text x="85.039,87.927,92.876,96.79400000000001,100.799,108.17,112.653,117.602,122.552,126.004,129.922,133.374,135.795,140.744,143.631,147.626,150.513,155.463,158.915,162.876,165.297,172.667,177.616,182.566,186.018,188.905,193.388,198.338,201.225,205.224,207.645,212.594,215.481,219.399,221.82,224.241,228.159,232.078,234.965,239.914,244.397,246.81799999999998,250.859,254.778,259.727,264.677,267.564,271.482,276.431,279.319,281.74,285.724,292.162,294.583,297.004,300.974,305.457,310.406,313.294,318.243,323.192,326.644" y="609.341" svg_rhmargin="330.096" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">the manuscript for important intellectual content. All authors</text>
  <text svg_rhmargin="173.1" x="85.039,88.491,92.41,96.893,101.842,104.824,109.308,114.257,119.206,122.229,126.712,131.661,136.611,140.063,145.012,149.495,153.414,158.363,161.345,164.232,169.182,173.1" y="620.34" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">read and approved the </text>
  <text x="176.089" y="620.34" svg_rhmargin="181.038" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="181.021,185.97,190.454,192.875,195.875,203.245,207.728,212.677,217.627,221.079,224.997,228.449,230.87,235.819,238.707" y="620.34" svg_rhmargin="241.128" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">nal manuscript.</text>
  <text svg_rhmargin="157.353" x="85.039,91.477,96.427,101.376,105.294,109.213,114.162,117.049,121.998,126.482,128.903,131.323,135.242,139.725,142.612,145.033,149.982,154.932,157.35299999999998" y="631.282" style="fill:#171615;font-family:MMNFFE+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Conceptualization: </text>
  <text x="160.384,163.836,168.786,173.735,180.639,185.58800000000002,188.616,195.52,200.47,204.953,209.902,212.32299999999998,215.318,224.284,226.705,231.655,236.138,239.128,245.566,250.049,254.998,259.482" y="631.282" svg_rhmargin="261.903" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Junwu Duan, Ming Yang.</text>
  <text svg_rhmargin="141.239" x="85.039,91.943,96.427,99.314,103.797,106.809,110.727,115.676,119.128,123.612,126.499,128.92,133.869,138.818,141.239" y="642.223" style="fill:#171615;font-family:MMNFFE+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Data curation: </text>
  <text x="144.227,147.679,152.628,157.578,164.482,169.431,172.459,179.363,184.313,188.796,193.745,196.166,199.161,204.576,206.997,211.947,214.368,216.788,221.73700000000002,224.728,229.678,234.161,239.11" y="642.223" svg_rhmargin="241.531" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Junwu Duan, Linlin Pan.</text>
  <text svg_rhmargin="148.218" x="85.039,89.989,94.938,98.39,105.761,110.244,112.665,115.652,120.135,125.085,129.568,131.989,136.472,139.924,142.345,145.797,148.218" y="653.221" style="fill:#171615;font-family:MMNFFE+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Formal analysis: </text>
  <text x="151.257,154.709,159.659,164.608,171.512,176.461,179.433,186.337,191.286,195.77,200.719,203.14,206.135,211.55,213.971,218.921,221.342,223.762,228.711,231.759,236.709,241.192,246.141" y="653.221" svg_rhmargin="248.562" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Junwu Duan, Linlin Pan.</text>
  <text svg_rhmargin="136.632" x="85.039,87.927,92.876,97.359,101.277,104.729,107.617,110.037,114.521,119.004,121.891,124.312,129.261,134.211,136.632" y="664.163" style="fill:#171615;font-family:MMNFFE+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Investigation: </text>
  <text x="139.692,145.107,147.528,152.478,154.899,157.319,162.268,165.259,170.209,174.692,179.641" y="664.163" svg_rhmargin="182.062" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Linlin Pan.</text>
  <text svg_rhmargin="139.366" x="85.039,94.006,97.924,100.811,105.761,110.71,115.659,120.609,123.03,127.979,132.462,136.945,139.36599999999999" y="675.104" style="fill:#171615;font-family:MMNFFE+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Methodology: </text>
  <text x="142.356,145.809,150.758,155.707,162.611,167.56,170.589,177.493,182.442,186.925,191.875" y="675.104" svg_rhmargin="194.296" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Junwu Duan.</text>
  <text svg_rhmargin="127.863" x="85.039,91.477,95.96,98.381,100.802,105.752,110.235,113.122,115.543,120.492,125.442,127.863" y="686.046" style="fill:#171615;font-family:MMNFFE+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Validation: </text>
  <text x="130.904,136.319,138.74,143.69,146.111,148.532,153.48100000000002,156.471,161.421,165.904,170.853" y="686.046" svg_rhmargin="173.274" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Linlin Pan.</text>
  <text svg_rhmargin="114.619" x="85.039,94.006,97.458,99.879,102.766,105.187,110.136,114.619" y="697.044" style="fill:#171615;font-family:MMNFFE+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Writing </text>
  <text svg_rhmargin="122.121" x="117.638,122.12100000000001" y="697.044" style="fill:#171615;font-family:MMNFFF+AdvOT66af078c.B+20;font-size:8.97px;font-style:NORMAL;font-weight:normal;">– </text>
  <text svg_rhmargin="178.742" x="125.121,130.071,133.523,135.944,140.427,142.848,147.797,152.28,154.701,157.662,162.611,166.063,170.547,173.434,176.321,178.742" y="697.044" style="fill:#171615;font-family:MMNFFE+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">original draft: </text>
  <text x="181.758,185.21,190.159,195.109,202.013,206.96200000000002,209.99,216.894,221.844,226.327,231.276" y="697.044" svg_rhmargin="233.697" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Junwu Duan.</text>
  <text svg_rhmargin="114.619" x="85.039,94.006,97.458,99.879,102.766,105.187,110.136,114.619" y="707.986" style="fill:#171615;font-family:MMNFFE+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Writing </text>
  <text svg_rhmargin="122.121" x="117.638,122.12100000000001" y="707.986" style="fill:#171615;font-family:MMNFFF+AdvOT66af078c.B+20;font-size:8.97px;font-style:NORMAL;font-weight:normal;">– </text>
  <text svg_rhmargin="193.029" x="125.121,128.573,132.492,136.975,139.396,143.314,150.218,153.183,161.584,164.579,168.497,173.446,175.867,178.754,181.175,186.125,190.608,193.029" y="707.986" style="fill:#171615;font-family:MMNFFE+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">review &amp; editing: </text>
  <text svg_rhmargin="242.629" x="196.045,205.011,207.432,212.381,216.864,219.855,226.293,230.776,235.725,240.208,242.629" y="40.71199999999999" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Ming Yang. </text>
  <text x="345.09,351.885,357.602,361.047,366.764,370.701,376.418,382.333,387.851,393.567" y="40.71199999999999" svg_rhmargin="398.791" style="fill:#171615;font-family:MMHCLG+AdvOTfbba3ace.B;font-size:9.46px;font-style:NORMAL;font-weight:normal;">References</text>
  <text x="349.342,351.748,355.872,358.278,361.586,365.322,367.34,370.605,374.341,377.606,379.623,381.371,386.736,391.249,393.266,394.976,402.448,404.466,406.483,408.5,411.766,414.64300000000003,416.348,421.713,427.466,429.483,431.2,434.077,437.342,443.484,447.22,449.237,450.928,456.293,458.31,459.998,465.363,469.099,473.223,476.488,479.754,482.63100000000003,484.374,487.251,489.657,493.393,495.799,497.816,500.693,503.099,505.116,508.381,511.258,513.275,515.042,519.167,523.291,527.416,531.54,533.557,535.224,540.589,545.9540000000001,547.639,553.004,556.74,560.865,564.13,567.48,570.357,572.016,574.8929999999999,576.551,581.916,583.934,585.951" y="55.16899999999998" svg_rhmargin="590.075" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin</text>
  <text x="361.587,365.712,369.836,373.96,378.085,380.102,384.227,388.351,390.441" y="64.12599999999998" svg_rhmargin="394.565" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2018;68:7</text>
  <text x="394.582" y="64.12599999999998" svg_rhmargin="398.318" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="398.324,402.449,406.574" y="64.12599999999998" svg_rhmargin="408.591" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">30.</text>
  <text x="349.342,351.748,355.872,358.278,361.586,369.058,372.794,374.811,377.688,381.881,388.022,391.758,395.883,397.3,402.202,404.219,405.634,411.0,415.124,417.53,420.407,423.672,426.548,429.425,430.861,436.226,438.632,440.649,442.085,448.31,451.575,454.452,458.576,462.312,466.436,470.561,473.826,477.091,478.536,483.901,485.918,487.38,490.645,493.051,494.466,498.202,500.219,502.236,503.65,508.163,512.287,515.552,519.288,521.3050000000001,522.754,525.63,528.896,532.161,536.285,539.162,542.038,545.304,549.428,552.693,555.958,557.39,561.126,565.25,569.375,570.825,574.95,577.826,581.091,584.827,587.704" y="73.13999999999999" svg_rhmargin="590.11" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[2] Maishman T, Cutress RI, Hernandez A, et al. Local recurrence and breast</text>
  <text x="361.587,365.712,369.836,373.101,377.226,379.243,383.367,387.103,389.194,392.459,396.195,398.212,401.835,404.712,408.837,411.713,415.449,418.714,421.591,425.327,428.989,431.007,435.132,438.74,442.476,446.6,450.725,454.849,458.585,462.266,468.019,472.144,478.285,481.551,485.676,489.306,495.06,497.078,499.484,503.609,507.277,511.402,514.278,517.544,521.28,524.156,526.5619999999999,530.236,533.501,537.237,541.362,544.627,547.892,550.769,552.7860000000001,556.426,558.832,562.957,566.222,569.862,573.987,580.128,583.864" y="82.09699999999998" svg_rhmargin="590.088" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">oncological surgery in young women with breast cancer: the POSH</text>
  <text x="361.587,367.729,371.853,374.73,377.995,380.872,384.608,388.344,390.838,392.855,396.98,401.104,404.84,406.85699999999997,409.375,414.74,418.864,422.989,427.113,429.99,432.396,434.885,438.621,441.027,445.151,449.34,453.076,455.093,457.56,462.925,467.049,471.174,473.716,477.452,481.577,484.453,488.18899999999996,490.666,494.791,498.915,503.039,507.164,509.181,513.306,517.43,521.555,523.572,527.696,531.821" y="91.05399999999997" svg_rhmargin="535.945" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Observational Cohort Study. Ann Surg 2017;266:165</text>
  <text x="536.031" y="91.05399999999997" svg_rhmargin="539.767" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="539.772,543.898,548.023" y="91.05399999999997" svg_rhmargin="550.04" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">72.</text>
  <text x="349.342,351.748,355.873,358.279,361.587,369.059,372.324,376.449,380.634,384.759,387.494,394.967,396.984,399.74,404.642,407.907,412.032,414.82,420.185,426.409,428.426,431.203,436.568,440.692,444.817,448.553,451.328,456.693,461.206,463.223,466.01,471.375,473.392,475.409,479.534,481.551,484.816,488.552,490.569,493.39,497.126,501.251,505.376,508.13,511.007,515.131,518.396,520.488,524.224,526.2410000000001,528.992,533.116,535.993,540.117,544.242,546.259,549.525,555.666,558.543,561.361,563.379,567.504,570.262,573.998,578.122,582.247,586.371" y="100.01199999999994" svg_rhmargin="590.107" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[3] Menon M, Teh CH, Chua CL. Clinical and social problems in young</text>
  <text x="361.588,367.341,371.466,377.607,380.873,384.998,387.552,393.306,395.323,397.729,401.854,404.389,408.514,411.39,414.656,418.391,421.268,423.674,426.158,429.423,433.159,436.035,439.301,441.318,445.442,449.567,455.806,459.542,461.55899999999997,464.025,469.39,473.515,476.391,478.797,481.315,487.457,489.989,495.354,497.813,500.69,503.199,506.934,511.059,513.936,517.672,520.205,524.33,528.454,532.578,536.703,538.72,542.845,546.969,548.987,553.111,557.236" y="108.96900000000005" svg_rhmargin="561.36" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">women with breast carcinoma. Aust N Z J Surg 2010;62:364</text>
  <text x="561.429" y="108.96900000000005" svg_rhmargin="565.165" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="565.171,569.296" y="108.96900000000005" svg_rhmargin="571.313" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">7.</text>
  <text x="349.342,351.748,355.873,358.279,361.587,369.059,372.795,375.672,378.077,380.095,384.219,387.484,389.591,392.856,396.981,401.326,405.839,407.856,412.267,418.02,421.285,425.021,429.146,431.552,435.676,439.8,441.817,446.223,451.589,453.606,458.015,462.529,465.794,468.671,471.077,475.201,477.607,480.013,484.138,488.571,490.977,492.99399999999997,497.358,500.623,503.029,507.449,511.184,513.202,515.219,519.637,525.001,529.126,532.002,534.879,538.144,540.162,543.898,546.304,548.321,552.445,556.57,559.447,563.853,567.978,571.243,573.717,579.471,582.736,586.001" y="117.92600000000004" svg_rhmargin="590.125" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[4] Martincich L, Deantoni V, Bertotto I, et al. Correlations between</text>
  <text x="361.588,365.712,367.73,370.136,372.542,376.666,379.543,381.56,385.684,389.809,392.313,398.067,401.332,403.349,407.085,411.21,413.616,416.881,421.006,423.945,425.963,432.104,435.84,439.648,441.665,445.79,449.526,452.46,456.196,460.32,464.445,467.369,471.493,474.37,477.635,481.371,484.248,486.654,489.591,492.856,496.592,500.716,503.982,507.247,510.124,513.06,517.184,519.202,523.326,529.468,533.204,536.081,540.205,543.558,546.435,549.312,551.3290000000001,554.273,558.786,562.91,565.7869999999999,568.729,574.094,577.83,581.954,583.972,588.096" y="126.88300000000004" svg_rhmargin="590.113" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">diffusion-weighted imaging and breast cancer biomarkers. Eur Radiol</text>
  <text x="361.588,365.712,369.837,373.961,378.086,380.103,384.227,388.352,390.442,394.566,398.691,402.815" y="135.89700000000005" svg_rhmargin="406.939" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2012;22:1519</text>
  <text x="406.942" y="135.89700000000005" svg_rhmargin="410.678" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="410.684,414.809,418.934" y="135.89700000000005" svg_rhmargin="420.951" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">28.</text>
  <text x="349.342,351.748,355.873,358.279,361.587,366.1,369.836,375.978,379.714,383.839,386.813,392.567,398.791,400.808,403.763,408.665,411.93,418.072,420.089,424.214,427.232,430.968,432.985,435.905,440.419,444.544,448.279,451.544,454.5,458.236,462.749,464.766,467.709,470.974,473.38,476.326,480.062,482.08,484.097,487.098,490.834,494.099,498.223,500.629,502.646,506.771,510.036,512.053,515.045,517.063,520.798,526.94,531.065,535.19,538.117,542.242,546.366,550.491,553.756,556.712,560.837,562.854,566.979,571.168,574.045,577.781,580.693,583.099,587.223" y="144.85400000000004" svg_rhmargin="590.1" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[5] Lyman GH, Temin S, Edge SB, et al. Sentinel lymph node biopsy for</text>
  <text x="361.588,365.712,369.448,371.854,373.872,377.137,381.261,383.753,386.63,390.159,395.913,397.93,400.336,404.461,408.073,411.338,415.074,417.951,419.968,423.704,426.11,428.987,431.392,435.128,438.864,442.12899999999996,445.77,449.895,452.772,456.037,459.773,462.649,465.055,468.673,471.938,475.674,479.798,483.064,486.329,489.205,491.222,494.806,500.171,506.313,509.578,512.455,514.472,517.822,521.558,525.683,529.217,532.953,537.077,540.343,542.36,545.625,548.031,551.7669999999999,555.407,559.532,561.938,565.498,570.863,572.88,574.897,579.022,581.039,584.305,588.04" y="153.812" svg_rhmargin="590.057" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">patients with early-stage breast cancer: American Society of Clinical</text>
  <text x="361.588,367.73,371.854,375.119,379.244,381.261,385.386,389.195,392.931,396.962,400.227,402.244,404.262,408.386,410.403,413.669,417.404,419.421,423.492,427.616,430.493,434.229,437.494,439.9,441.917,445.182,448.447,452.516,456.252,460.376,462.394,466.518,469.783,471.801,473.818,477.942,481.207,485.225,489.35,493.474,497.598,501.334,503.819,507.084,509.101,513.116,515.9929999999999,520.033,525.398,527.415,529.433,533.558,537.55,543.692,547.816,551.156,555.28,557.297,561.303,565.428,569.552,573.676,577.801,579.818,583.943,588.067" y="162.769" svg_rhmargin="590.084" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Oncology clinical practice guideline update. J Clin Oncol 2014;32:</text>
  <text x="361.588,365.713,369.838,373.964" y="171.726" svg_rhmargin="378.088" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">1365</text>
  <text x="378.142" y="171.726" svg_rhmargin="381.878" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="381.884,386.01,390.135" y="171.726" svg_rhmargin="392.152" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">83.</text>
  <text x="349.342,351.748,355.873,358.279,361.587,367.811,371.547,375.671,379.407,383.532,385.566,389.302,396.774,398.791,400.872,403.749,407.873,410.75,414.875,418.61,422.735,424.795,429.308,433.821,435.838,437.833,443.198,447.322,451.058,453.139,457.263,463.017,465.034,467.084,470.35,472.75600000000003,474.795,478.53,480.548,482.565,484.602,489.967,491.972,496.097,498.973,503.098,505.974,510.099,513.364,516.629,519.035,521.053,524.788,528.053,530.123,533.389,537.513,543.729,547.853,551.589,554.466,556.483,559.36,563.484,567.609,569.636,573.761,576.1669999999999,578.197,582.71,588.075" y="180.683" svg_rhmargin="590.092" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[6] Hadad SM, Jordan LB, Roy PG, et al. A prospective comparison of ER,</text>
  <text x="361.588,365.712,371.077,375.024,380.388,382.406,386.53,390.655,394.638,398.374,402.498,406.623,410.568,414.304,417.569,421.693,424.95799999999997,428.878,432.143,436.268,440.392,443.334,446.599,449.476,452.352,454.37,458.494,462.619,466.576,468.594,472.719,476.668,480.792,484.528,486.545,489.422,492.687,496.812,500.76,503.637,506.902,511.027,515.151,518.416,522.541,524.947,526.964,530.7,532.7170000000001,536.701,539.966,544.09,546.967,550.232,554.161,558.285,560.303,564.427,568.617,571.493,573.511,576.776,579.6529999999999,583.583,587.707" y="189.697" svg_rhmargin="590.113" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">PR Ki67 and gene expression in paired sequential core biopsies of</text>
  <text x="361.588,365.712,368.589,370.606,376.748,380.484,383.361,387.097,389.114,391.69,395.814,399.938,402.344,405.221,408.486,412.222,414.628,417.893,422.018,424.568,428.693,431.57,434.835,438.571,441.447,443.853,446.337,449.602,453.338,457.462,460.792,464.058,466.934,468.951,471.45,475.963,483.435,488.8,491.292,496.656,500.392,504.517,507.782,511.047,513.924,516.461,520.585,524.71,528.834,532.959,534.976,539.101,543.225,545.242,549.367,553.491,557.616" y="198.654" svg_rhmargin="559.633" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">primary, untreated breast cancer. BMC Cancer 2016;16:745.</text>
  <text x="349.342,351.748,355.873,358.279,361.587,366.1,370.225,373.96,376.837,379.243,382.12,386.244,392.386,397.358,404.83,407.707,411.831,413.848,418.787,424.929,429.053,433.177,436.913,441.038,443.055,447.981,451.717,453.734,458.639,464.863,468.599,472.335,475.6,479.725,484.66,490.024,492.43,494.447,499.399,502.664,505.07,510.0,513.736,515.753,517.7700000000001,522.642,530.114,534.239,536.256,539.592,542.857,546.982,548.999,552.735,555.612,560.51,563.387,567.511,571.636,574.042,577.778,581.902,585.167,588.117" y="207.61199999999997" svg_rhmargin="590.134" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[7] Engstrøm MJ1, Opdahl S, Hagen AI, et al. Molecular subtypes,</text>
  <text x="361.588,365.712,367.73,370.606,373.012,377.137,381.261,384.997,387.494,391.619,395.743,397.76,401.885,405.621,407.638,410.903,414.639,416.656,418.446,422.182,425.059,428.794,432.919,436.18399999999997,437.947,441.683,445.807,449.932,451.666,454.542,458.667,461.543,465.279,467.368,471.104,474.84,476.85699999999997,478.592,480.61,484.735,486.472,490.20799999999997,491.971,496.096,498.113,500.99,503.396,507.52,510.397,512.414,515.679,517.481,520.746,524.871,528.995,533.12,535.996,538.4019999999999,540.213,544.338,546.7439999999999,548.49,552.614,555.491,558.756,562.492,565.369,567.775,569.578,572.844,576.579,580.704,583.969,587.234" y="216.56899999999996" svg_rhmargin="590.111" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">histopathological grade and survival in a historic cohort of breast cancer</text>
  <text x="361.588,365.712,369.448,371.854,373.872,377.137,381.261,383.753,386.63,388.647,391.122,395.636,398.513,401.778,405.514,408.391,410.797,413.345,418.71,422.446,426.57,429.835,433.1,435.97700000000003,438.515,443.879,447.144,450.021,452.517,457.419,460.296,463.561,467.297,469.70300000000003,472.188,476.313,480.437,484.562,488.686,490.782,494.906,499.031,503.155,505.173,509.297,513.421" y="225.52599999999995" svg_rhmargin="517.545" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">patients. Breast Cancer Res Treat 2013;140:463</text>
  <text x="517.549" y="225.52599999999995" svg_rhmargin="521.285" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="521.291,525.416,529.541" y="225.52599999999995" svg_rhmargin="531.558" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">73.</text>
  <text x="349.342,351.748,355.873,358.279,361.587,364.464,366.481,370.217,374.342,378.078,381.032,386.786,388.803,391.69,395.426,399.551,403.287,407.411,409.428,412.381,416.506,419.411,425.165,428.042,430.05899999999997,432.961,437.862,441.987,445.252,448.153,450.171,456.312,462.454,466.579,470.703,473.96799999999996,476.951,479.828,483.564,486.44,488.846,492.111,498.253,501.157,504.893,509.018,513.143,516.067,518.084" y="234.48299999999995" svg_rhmargin="522.208" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[8] Jiang X, Shapiro DJ. The immune system and in</text>
  <text x="522.255" y="234.48299999999995" svg_rhmargin="526.379" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="526.393,530.129,536.271,542.413,546.149,548.555,550.572,554.697,558.822,561.767,563.785,567.91,570.838,574.963,577.839,581.104,584.84,587.717" y="234.48299999999995" svg_rhmargin="590.123" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ammation in breast</text>
  <text x="361.588,364.853,368.589,372.713,375.979,379.244,382.12,384.137,386.701,394.172,398.297,400.314,402.8,408.166,411.431,413.448,415.465,417.993,422.506,426.631,430.755,434.88,438.145,441.021,443.039,447.163,451.288,453.305,455.861,459.985,464.11,468.234,472.359,474.376,478.501,482.625,486.749,488.767,492.891,497.016" y="243.44000000000005" svg_rhmargin="501.14" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cancer. Mol Cell Endocrinol 2014;382:673</text>
  <text x="501.222" y="243.44000000000005" svg_rhmargin="504.958" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="504.964,509.089,513.214" y="243.44000000000005" svg_rhmargin="515.231" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">82.</text>
  <text x="349.342,351.748,355.873,358.279,361.587,367.811,371.936,375.671,379.796,383.532,389.591,394.957,396.974,403.028,408.393,412.129,416.254,422.304,426.04,428.057,434.152,439.054,442.79,446.914,450.65,456.658,461.171,463.188,469.244,474.145,478.27,481.53499999999997,487.612,490.018,494.142,500.284,504.408,507.285,513.348,519.49,521.508,524.773,527.649,531.774,535.039,539.163,542.899,544.917,547.793,552.01,556.134,562.276,565.541,569.666,572.072,578.143,581.879,586.004" y="252.45399999999995" svg_rhmargin="590.128" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[9] Huang A, Cao S, Tang L. The tumor microenvironment and</text>
  <text x="361.588,363.605" y="261.41200000000003" svg_rhmargin="367.729" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">in</text>
  <text x="367.767" y="261.41200000000003" svg_rhmargin="371.891" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="371.906,375.642,381.783,387.925,391.661,394.067,398.192,401.068,404.804,407.336,411.461,414.337,417.603,421.338,424.215,426.621,429.161,432.427,436.162,440.287,443.552,446.817,449.694,451.711,454.217,457.094,459.603,464.968,468.704,472.829,476.094,479.359,482.236,484.773,488.898,493.022,497.146,501.271,503.288,507.413,509.43,513.555,517.679,521.803" y="261.41200000000003" svg_rhmargin="525.927" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ammatory breast cancer. J Cancer 2017;8:1884</text>
  <text x="525.996" y="261.41200000000003" svg_rhmargin="529.732" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="529.738,533.863,537.988" y="261.41200000000003" svg_rhmargin="540.005" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">91.</text>
  <text x="345.204,347.61,351.734,355.859,358.265,361.587,367.729,369.746,373.482,377.607,379.331,384.696,386.713,388.345,393.247,396.983,401.108,402.801,405.678,407.695,409.377,413.891,415.908,417.597,423.351,425.368,427.009,430.274,432.68,434.378,438.114,440.131,442.14799999999997,443.845,447.969,451.235,454.111,456.129,460.253,464.377,467.643,470.519,474.255,476.272,477.971,479.988" y="270.369" svg_rhmargin="484.112" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[10] Qian Y, Tao J, Li X, et al. Peripheral in</text>
  <text x="484.158" y="270.369" svg_rhmargin="488.282" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="488.296,492.032,498.174,504.316,508.052,510.458,512.475,516.599,520.724,522.741,524.759,530.901,537.042,541.167,545.291,548.556,550.313,552.33,556.455,560.579,562.597,565.862,569.598,572.004,576.128,579.005,581.882,583.589,587.713" y="270.369" svg_rhmargin="590.119" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ammation/immune indicators of</text>
  <text x="361.589,364.854,368.978,372.243,378.385,382.51,385.386,388.742,392.866,395.743,397.76,400.166,402.184,405.92,407.937,410.343,414.079,417.313,421.049,425.174,429.299,432.507,436.632,439.508,443.633,447.369,451.493,455.617,458.494,460.512,463.389,466.634,468.651,472.776,475.988,480.112,482.989,486.254,489.99,492.867,495.273,498.493,501.758,505.494,509.618,512.884,516.149,519.026,522.246,526.37,530.106,532.512,534.604,537.869,541.994,544.4,547.2769999999999,550.477,552.883,555.76,559.025,562.761,565.167,568.432,572.557,575.817,581.571,583.588,585.994" y="279.326" svg_rhmargin="590.118" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">chemosensitivity and prognosis in breast cancer patients treated with</text>
  <text x="361.589,365.713,368.978,373.103,376.839,380.963,382.98,387.105,390.841,394.577,398.776,401.182,403.651,406.916,411.041,414.306,420.448,424.572,427.063,431.188,434.454,437.33,441.066,445.191,448.926,450.943,453.424,459.566,463.69,467.029,471.154,473.606,478.508,482.244,485.121,488.856,492.122,494.527,497.404,499.966,504.868,508.992,512.257,515.1339999999999,517.653,521.778,525.902,530.027,534.151,536.169,540.293,544.418,546.435,550.559,554.684,558.808" y="288.283" svg_rhmargin="562.932" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">neoadjuvant chemotherapy. Onco Targets Ther 2018;11:1423</text>
  <text x="562.96" y="288.283" svg_rhmargin="566.696" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="566.702,570.828,574.953" y="288.283" svg_rhmargin="576.97" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">32.</text>
  <text x="345.205,347.61,351.735,355.859,358.265,361.588,369.06,372.325,374.342,378.311,382.825,384.842,388.799,394.165,397.901,402.026,405.977,413.449,415.466,419.413,425.166,427.184,431.308,435.044,439.027,444.392,446.409,450.365,453.63,456.036,460.002,463.738,465.755,467.772,471.68,476.582,480.706,483.971,487.95,492.075,495.34,499.464,501.87,504.747,508.871,512.996,517.12,519.138,521.1550000000001,525.137,527.155,530.891,537.033,541.157,545.281,549.406,552.744,556.48,558.886,562.151,566.067,568.943,572.679,575.085,577.178,581.303,585.228,587.245" y="297.24" svg_rhmargin="590.122" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[11] Wei B, Yao M, Xing C, et al. The neutrophil lymphocyte ratio is</text>
  <text x="361.589,365.325,368.201,371.078,375.202,378.467,380.485,384.221,386.627,389.892,394.017,396.735,402.489,404.506,406.912,411.037,413.742,417.866,420.743,424.008,427.744,430.621,433.027,435.737,439.002,442.738,446.863,450.128,453.393,456.27,458.98,463.104,465.981,470.105,473.841,477.966,482.09,484.967,486.984,489.861,491.878,494.58,498.316,502.441,505.124,509.249,513.373,517.497,521.233,523.639,526.904,531.029,533.695,536.572,540.307,543.184,545.59,548.855,554.997,558.733,561.139,563.156,566.4209999999999,569.182,572.058,575.323,579.059,581.077,584.342" y="306.254" svg_rhmargin="590.095" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">associated with breast cancer prognosis: an updated systematic review</text>
  <text x="361.589,365.325,369.449,373.574,376.101,382.243,385.508,387.914,391.65,394.056,397.792,401.916,405.652,407.669,411.405,414.282,416.299,419.176,421.193,423.776,429.918,434.042,437.307,441.432,443.957,448.859,452.594,455.471,459.207,462.472,464.878,467.755,470.261,475.162,479.287,482.552,485.42900000000003,487.948,492.072,496.197,500.321,504.446,506.463,510.587,512.605,516.803,520.927,525.051" y="315.212" svg_rhmargin="529.175" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">and meta-analysis. Onco Targets Ther 2016;9:5567</text>
  <text x="529.172" y="315.212" svg_rhmargin="532.908" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="532.914,537.039,541.164" y="315.212" svg_rhmargin="543.181" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">75.</text>
  <text x="345.205,347.611,351.736,355.86,358.266,361.589,366.953,371.078,374.343,378.468,382.791,385.667,387.68399999999997,391.974,397.728,400.993,405.118,408.854,413.12,419.262,421.279,425.592,429.716,433.452,437.577,441.805,447.171,449.188,453.484,456.749,459.15500000000003,463.462,467.198,469.215,471.23199999999997,475.537,479.662,482.538,486.663,490.399,494.523,498.648,501.524,503.93,505.947,509.212,513.519,517.255,520.99,523.008,527.132,530.3969999999999,534.664,538.788,541.194,545.492,549.617,552.882,557.006,559.412,562.289,566.413,570.538,574.662,576.68,578.697,581.103,583.509,587.633" y="324.169" svg_rhmargin="590.039" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[12] Chen J, Deng Q, Pan Y, et al. Prognostic value of neutrophil-to-</text>
  <text x="361.589,363.607,367.343,373.485,377.609,381.733,385.858,389.196,392.932,395.338,398.603,401.101,403.978,407.714,410.12,412.137,416.262,418.788,420.806,424.931,427.406,431.53,434.407,437.672,441.408,444.355,446.761,449.231,452.496,456.232,460.356,463.621,466.886,469.763,471.78,474.343,478.468,481.733,485.857,488.73400000000004,491.236,497.378,501.503,504.768,508.893,511.418,515.931,517.948,522.073,524.569,528.695,532.819,536.944,541.068,543.085,547.21,549.227,553.352,557.476" y="333.126" svg_rhmargin="561.6" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">lymphocyte ratio in breast cancer. Febs Open Bio 2015;5:502</text>
  <text x="561.657" y="333.126" svg_rhmargin="565.393" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="565.399,569.524" y="333.126" svg_rhmargin="571.541" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">7.</text>
  <text x="345.205,347.611,351.736,355.86,358.266,361.589,366.953,370.689,374.814,376.215,383.687,385.704,387.1,391.613,393.631,397.756,399.176,404.54,406.557,407.962,410.839,412.856,416.981,418.393,424.617,426.634,428.03,431.295,433.701,435.116,438.852,440.87,442.887,444.3,448.424,451.301,455.425,459.161,463.286,467.41,470.287,472.693,474.71,477.97499999999997,479.39,483.126,486.862,488.879,493.003,496.268,497.7,501.825,504.231,505.637,509.761,512.638,515.903,520.027,524.152,527.417,530.294,534.03,536.435,538.453,542.189,545.454,546.906,548.923" y="342.083" svg_rhmargin="553.047" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[13] Yao M, Liu Y, Jin H, et al. Prognostic value of preoperative in</text>
  <text x="553.04" y="342.083" svg_rhmargin="557.164" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="557.179,560.915,567.057,573.198,576.934,579.34,583.465,586.43" y="342.083" svg_rhmargin="590.166" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ammatory</text>
  <text x="361.589,367.731,371.467,374.344,378.468,381.733,384.61,387.487,391.238,393.255,397.38,401.102,406.467,410.591,412.608,416.805,420.07,422.946,426.211,429.9,434.024,437.76,440.166,442.183,445.448,449.573,451.979,454.856,458.641,464.394,466.411,468.817,472.942,476.668,480.792,483.669,486.934,490.67,493.547,495.95300000000003,499.683,502.948,506.684,510.809,514.074,517.339,520.216,522.2330000000001,525.987,532.129,536.253,539.518,543.643,547.415,552.317,556.053,558.929,562.665,565.931,568.336,571.213,574.966,579.868,583.992,587.257" y="351.04" svg_rhmargin="590.134" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">markers in Chinese patients with breast cancer. Onco Targets Ther</text>
  <text x="361.589,365.714,369.838,373.963,378.087,380.105,384.229,386.246,390.444,394.568,398.693" y="359.998" svg_rhmargin="402.817" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2014;7:1743</text>
  <text x="402.805" y="359.998" svg_rhmargin="406.541" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="406.547,410.672,414.797" y="359.998" svg_rhmargin="416.814" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">52.</text>
  <text x="345.205,347.611,351.736,355.86,358.266,361.589,364.465,366.483,370.219,371.907,379.378,381.395,383.131,390.602,394.727,396.396,399.273,401.29,402.972,405.849,407.866,411.602,413.347,419.571,421.588,423.267,426.532,428.938,430.636,434.372,436.39,438.407,440.103,445.005,449.129,452.394,454.105,458.23,461.495,464.372,466.389,470.513,474.638,477.903,480.78,484.515,486.532,488.288,492.412,494.43,498.554,502.679,506.804,508.469,512.594,515.859,519.983,522.389,525.266,529.39,533.515,537.72,539.737,541.755,544.161,546.567,550.691,553.097,555.114,558.85,564.992,569.117,573.241,577.366,580.631,584.367,586.773" y="369.012" svg_rhmargin="590.038" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[14] Jia W, Wu J, Jia H, et al. The peripheral blood neutrophil-to-lymphocyte</text>
  <text x="361.589,364.466,368.202,370.608,372.625,376.75,378.993,381.01,383.887,386.079,388.956,393.08,397.205,400.47,403.346,405.364,409.488,412.365,414.593,416.999,421.124,423.324,425.73,429.854,433.11899999999997,435.342,437.359,441.095,447.237,451.362,455.486,459.61,462.876,466.612,469.017,472.283,474.689,477.094,481.219,483.625,489.767,493.891,498.015,502.14,505.521,509.257,511.663,514.928,517.142,520.019,523.755,526.161,528.178,532.303,534.489,536.895,541.019,543.896,546.111,550.235,553.112,556.377,560.501,562.519,565.784,568.19,570.207,574.332,578.068,580.294,582.7,586.824" y="377.969" svg_rhmargin="590.089" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ratio is superior to the lymphocyte-to-monocyte ratio for predicting the</text>
  <text x="361.589,363.607,367.731,371.856,375.592,377.998,380.403,383.755,386.631,392.77299999999997,395.659,398.536,402.66,405.537,409.273,411.29,415.026,418.762,420.779,423.72,427.844,430.25,433.187,435.593,438.47,440.487,444.612,446.629,449.894,452.3,456.424,459.69,463.426,467.161,469.567,471.585,475.321,478.586,481.542,485.667,488.544,491.809,495.545,498.421,500.827,503.764,507.029,510.765,514.89,518.155,521.42,524.2969999999999,527.233,531.358,535.094,537.5,539.517,542.782,546.907,549.313,552.189,554.206,557.165,561.289,565.802,569.927,573.663,576.552,582.694,586.819" y="386.926" svg_rhmargin="590.084" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">long-term survival of triple-negative breast cancer patients. PLoS One</text>
  <text x="361.589,365.714,369.838,373.963,378.087,380.105,384.229,388.353,390.443,393.708,397.833,401.957,406.082,410.206,414.331,418.455,422.579" y="395.883" svg_rhmargin="424.596" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2015;10:e0143061.</text>
  <text x="345.205,347.611,351.736,355.861,358.267,361.589,367.028,371.227,374.566,378.691,380.065,386.208,388.225,389.646,395.085,398.895,403.093,406.829,408.196,412.783,418.537,420.554,421.967,426.559,428.576,429.961,435.8,441.554,443.57099999999997,444.985,448.324,450.73,452.066,455.876,457.967,459.984,461.368,466.357,470.555,473.82,475.148,478.487,480.578,483.917,487.727,491.537,493.943,497.319,501.444,502.819,507.017,509.968,513.307,517.505,521.63,524.989,527.94,531.749,534.229,536.321,540.131,543.396,544.723,548.921,552.26,556.459,558.939,561.815,566.025,570.223,574.422,576.513,578.605,581.011,583.537,587.732" y="404.84" svg_rhmargin="590.138" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[15] Chen Q, Yang LX, Li XD, et al. The elevated preoperative neutrophil-to-</text>
  <text x="361.589,363.681,367.491,373.707,377.905,382.031,386.24,389.58,393.389,395.869,399.134,402.56,405.51,409.32,411.727,413.857,417.982,421.397,425.594,428.544,431.883,436.082,438.173,441.439,443.957,446.834,450.251,454.449,458.647,462.846,465.723,469.139,473.338,476.288,480.487,484.297,488.495,492.693,495.644,497.662,500.539,504.036,506.054,510.179,513.674,515.692,519.912,522.392,525.342,529.152,533.351,536.617,540.835,544.645,547.125,549.216,552.481,555.907,559.246,563.444,567.569,569.682,573.492,577.69,581.5,583.591,587.79" y="413.797" svg_rhmargin="590.196" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">lymphocyte ratio predicts poor prognosis in intrahepatic cholangio-</text>
  <text x="361.589,364.929,368.738,371.689,375.028,377.12,381.243,385.442,391.658,395.394,398.8,402.994,406.804,409.21,411.338,414.683,418.881,421.286,424.163,427.61,431.809,436.007,440.206,443.47,446.421,450.23,454.429,456.52,460.719,464.455,467.861,472.059,475.324,479.522,483.332,485.812,489.151,492.415,494.932,499.13,505.346,509.156,511.173,514.541,519.516,523.715,529.857,534.088,538.286,541.1629999999999,544.578,549.091,551.21,555.409,557.426,560.851,565.049,569.173,573.371,577.57,579.661,583.859,588.058" y="422.811" svg_rhmargin="590.075" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">carcinoma patients undergoing hepatectomy. Tumour Biol 2015;36:</text>
  <text x="361.589,365.785,369.98,374.176" y="431.769" svg_rhmargin="378.3" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">5283</text>
  <text x="378.37" y="431.769" svg_rhmargin="382.106" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="382.169,386.364" y="431.769" svg_rhmargin="388.381" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="345.205,347.611,351.736,355.86,358.266,361.589,366.953,368.971,373.095,376.831,380.956,383.811,389.175,393.688,395.705,398.493,403.857,406.734,409.611,411.628,415.364,419.489,422.302,427.667,429.68399999999997,432.507,437.871,441.136,443.542,445.56,449.684,453.809,457.545,461.281,464.138,471.61,475.735,477.752,480.522,483.787,486.193,489.025,492.761,494.779,496.796,499.57,504.083,507.819,511.084,515.2090000000001,518.05,522.175,524.5809999999999,527.348,531.472,534.349,538.473,542.209,546.395,550.519,553.396,555.802,557.819,561.084,563.912,567.648,571.384,573.401,577.525,580.79,583.583,587.708" y="440.726" svg_rhmargin="590.114" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[16] Cihan YB, Arslan A, Cetindag MF, et al. Lack of prognostic value of</text>
  <text x="361.589,365.714,367.731,371.856,375.98,380.105,382.281,386.406,390.141,393.018,396.754,402.896,406.161,408.567,411.832,414.709,417.586,419.809,421.826,425.951,428.086,432.211,435.947,438.352,440.37,443.635,447.759,450.165,453.04200000000003,455.24,458.117,461.382,464.647,467.912,469.93,473.666,475.683,479.807,483.543,485.739,489.474,493.599,495.616,499.741,503.477,507.212,511.337,513.7429999999999,515.897,518.774,522.51,526.634,528.651,532.776,535.182,539.306,542.571,545.448,549.184,553.308,557.044,559.263,561.669,565.794,568.6709999999999,570.828,574.953,577.829,581.095,584.831,587.707" y="449.683" svg_rhmargin="590.113" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">blood parameters in patients receiving adjuvant radiotherapy for breast</text>
  <text x="361.589,364.855,368.591,372.715,375.98,379.245,382.122,384.139,386.702,392.067,394.944,396.961,400.697,404.822,407.337,411.461,415.197,418.462,420.942,423.819,426.328,431.693,435.429,439.553,442.818,446.083,448.96000000000004,451.498,455.622,458.499,461.764,465.5,467.994,472.118,476.243,480.367,484.491,486.509,490.633,494.758,496.848,500.972,505.096,509.221" y="458.64" svg_rhmargin="513.345" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cancer. Asian Pac J Cancer Prev 2014;15:4225</text>
  <text x="513.355" y="458.64" svg_rhmargin="517.091" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="517.097,521.222,525.347" y="458.64" svg_rhmargin="527.364" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">31.</text>
  <text x="345.205,347.611,351.736,355.86,358.266,361.589,366.953,369.83,373.095,377.22,381.344,383.75,387.874,389.892,391.909,396.034,400.159,404.558,408.294,410.311,414.592,419.106,422.842,426.966,430.702,433.579,436.844,440.968,442.986,446.338,450.463,454.587,457.852,460.729,465.045,470.41,472.427,476.724,480.46,482.866,486.99,489.007,492.743,496.868,500.992,504.728,506.746,510.01099999999997,514.365,519.267,521.2840000000001,525.59,528.855,531.261,535.568,539.304,541.321,543.3380000000001,547.643,552.545,556.669,559.934,564.253,567.518,569.536,572.801,576.537,580.273,582.679,585.944" y="467.597" svg_rhmargin="590.068" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[17] Krenn-Pilko S, Langsenlehner U, Stojakovic T, et al. The elevated</text>
  <text x="361.589,365.714,368.591,371.856,375.98,380.105,383.37,386.246,389.982,392.388,394.406,398.141,401.406,407.11,411.234,414.499,417.376,419.393,423.129,426.395,430.52,436.192,440.316,443.581,447.706,450.111,452.988,457.113,461.237,465.361,467.379,469.396,471.802,474.208,478.332,480.738,482.756,486.492,492.633,496.758,500.882,505.123,508.388,512.124,514.53,517.795,523.434,526.311,530.047,532.453,534.47,538.595,544.24,548.364,551.241,554.506,558.63,560.648,563.913,566.319,569.1959999999999,574.852,578.976,583.101,587.225" y="476.555" svg_rhmargin="590.102" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">preoperative derived neutrophil-to-lymphocyte ratio predicts poor</text>
  <text x="361.589,364.855,366.872,368.889,373.014,375.031,378.296,382.032,384.049,386.022,390.147,394.271,396.677,399.942,404.067,410.285,413.55,415.444,417.461,421.586,423.494,427.618,430.495,433.76,437.496,440.444,442.85,444.753,448.018,451.754,455.878,459.143,462.409,465.286,467.202,471.326,475.062,477.468,479.56,482.825,486.95,489.356,492.232,494.249,496.17,501.071,505.196,511.338,515.462,519.586,522.463,524.401,528.914,530.932,535.056,537.0730000000001,539.027,543.152,547.276,551.401,555.525,557.543,561.667,565.791,567.809,571.933,576.058" y="485.569" svg_rhmargin="580.182" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">clinical outcome in breast cancer patients. Tumour Biol 2016;37:361</text>
  <text x="580.252" y="485.569" svg_rhmargin="583.988" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="583.994,588.12" y="485.569" svg_rhmargin="590.137" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">8.</text>
  <text x="345.205,347.611,351.736,355.86,358.266,361.589,366.953,371.078,375.203,376.838,382.203,384.21999999999997,385.852,392.076,396.2,400.325,404.061,405.636,409.372,413.497,415.514,417.144,419.55,425.692,427.292,431.028,436.393,438.40999999999997,440.047,443.312,445.718,447.304,451.04,453.057,455.074,456.714,460.839,463.715,467.84,471.576,475.7,479.825,482.701,485.107,487.125,490.39,492.031,495.767,499.503,501.52,505.645,508.90999999999997,510.512,514.636,517.0419999999999,518.676,521.552,525.288,528.165,530.571,533.836,539.978,541.995,545.26,546.907,548.924" y="494.526" svg_rhmargin="553.048" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[18] Cho U, Hong SP, Im SY, et al. Prognostic value of systemic in</text>
  <text x="553.04" y="494.526" svg_rhmargin="557.164" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="557.179,560.915,567.057,573.198,576.934,579.34,583.465,586.43" y="494.526" svg_rhmargin="590.166" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ammatory</text>
  <text x="361.589,367.731,371.467,374.344,378.468,381.733,384.61,387.487,390.217,393.953,398.077,402.202,404.843,408.967,412.233,415.968,419.234,421.251,425.375,429.5,435.642,438.907,443.031,445.437,448.152,452.277,454.683,457.336,461.072,463.686,467.81,471.934,478.141,482.266,486.001,488.878,492.614,498.756,501.44,503.458,507.583,510.227,514.352,517.228,520.494,524.229,527.106,529.512,532.166,535.431,539.167,543.292,546.557,549.822,552.699,554.716,557.392,561.517,566.03,570.154,573.89,576.553,582.695,586.819" y="503.483" svg_rhmargin="590.084" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">markers and development of a nomogram in breast cancer. PLoS One</text>
  <text x="361.589,365.714,369.838,373.963,378.087,380.105,384.229,388.353,390.443,393.708,397.833,401.957,406.082,410.206,414.331,418.455,422.579" y="512.44" svg_rhmargin="424.596" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2018;13:e0200936.</text>
  <text x="345.205,347.611,351.736,355.86,358.266,361.589,365.325,369.449,373.185,379.327,382.203,385.469,388.734,391.611,394.638,399.151,401.168,404.218,411.69,415.815,419.939,423.204,426.081,429.105,434.859,436.876,439.877,445.242,447.26,450.995,453.872,457.997,461.262,464.31,471.782,473.799,476.782,480.047,482.45300000000003,485.456,489.192,491.209,493.226,496.228,500.352,503.229,506.494,508.9,512.165,515.042,517.918,521.183,525.308,528.37,531.246,534.512,538.636,542.76,545.637,548.043,550.06,554.185,557.9209999999999,560.966,562.983,565.389,568.654,574.796,577.673,580.693,583.099,587.224" y="521.3969999999999" svg_rhmargin="590.101" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[19] Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for</text>
  <text x="361.589,364.466,368.202,371.079,373.485,376.75,382.892,386.627,389.033,391.051,394.316,399.911,402.787,406.053,409.789,411.806,415.071,420.824,426.442,430.178,434.302,438.427,443.959,450.101,453.366,455.772,459.508,461.914,465.65,469.774,473.51,475.528,479.264,482.14,484.264,487.141,492.655,496.78,499.656,503.781,506.187,510.311,513.576,517.701,519.718,522.5949999999999,528.199,530.605,534.73,540.095,542.5,546.236,553.708,559.073,561.479,565.603,568.0089999999999,573.607,577.732,581.856,585.981" y="530.354" svg_rhmargin="590.105" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">systematic review and meta-analysis protocols (PRISMA-P) 2015</text>
  <text x="361.589,364.855,366.872,370.608,374.732,378.857,381.733,385.469,387.875,389.893,394.017,398.142,400.704,404.44,408.565,412.69,415.217,418.482,422.606,426.731,428.748,432.484,436.608,440.344,442.75,444.768,448.892,453.017,455.034,457.562,462.075,469.547,472.42400000000004,474.966,479.09,483.215,487.339,491.463,493.481,497.605,501.73,505.854,507.871,511.607,515.732,519.856,523.981,528.105" y="539.3679999999999" svg_rhmargin="530.122" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">elaboration and explanation. BMJ 2015;349:g7647.</text>
  <text x="345.205,347.611,351.736,355.86,358.266,361.589,367.813,371.549,374.425,378.55,382.674,386.872,389.749,392.881,398.247,400.264,403.483,410.956,412.973,414.99,417.008,420.273,423.15000000000003,426.386,429.263,431.28,434.493,439.858,443.054,447.179,450.444,456.197,459.381,462.258,465.994,468.87,471.276,474.541,480.683,483.927,486.333,490.458,493.33500000000004,496.513,500.249,503.125,506.861,510.986,513.003,517.128,520.864,524.064,526.94,530.206,533.471,537.595,543.737,549.971,553.236,557.36,561.485,565.221,567.627,569.644,573.769,577.893,580.77,583.984,586.001" y="548.326" svg_rhmargin="590.125" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[20] Harbour R, Miller J. A new system for grading recommendations in</text>
  <text x="361.589,364.855,368.591,370.608,374.732,377.998,382.122,385.387,388.652,391.181,395.305,399.041,401.918,405.183,409.308,411.872,415.608,419.733,421.75,425.874,429.14,431.157,433.174,437.299,440.564,443.441,445.45799999999997,447.983,452.496,459.968,462.845,465.386,469.511,473.635,477.759,481.884,483.901,488.026,492.15,496.274,498.292,502.416,506.541" y="557.283" svg_rhmargin="510.665" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">evidence based guidelines. BMJ 2001;323:334</text>
  <text x="510.691" y="557.283" svg_rhmargin="514.427" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="514.433,518.558" y="557.283" svg_rhmargin="520.575" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">6.</text>
  <text x="345.205,347.611,351.736,355.86,358.266,361.589,367.813,369.83,373.566,377.302,379.319,383.444,386.321,388.402,391.279,395.403,400.305,402.322,404.388,409.289,413.414,417.538,423.68,427.804,430.681,434.806,438.931,441.009,444.745,450.498,452.515,454.614,460.368,463.633,466.898,471.023,473.90000000000003,475.93,478.806,481.683,483.7,485.794,489.059,491.46500000000003,493.504,497.24,499.257,501.274,503.311,510.783,514.048,517.784,520.661,524.853,527.729,529.747,533.871,537.607,539.648,541.666,545.79,549.055,553.18,557.304,560.181,562.198,565.075,567.481,570.746,574.871,578.136,581.872,583.979,585.996" y="566.24" svg_rhmargin="590.12" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[21] Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in</text>
  <text x="361.589,367.731,370.996,373.402,377.138,379.544,383.28,387.496,391.232,393.249,396.985,399.862,403.127,406.003,408.02,410.511,415.024,422.496,425.373,427.914,432.039,436.163,440.288,444.412,446.429,450.554,454.678,458.803,460.82,464.945,469.069" y="575.197" svg_rhmargin="473.193" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">meta-analyses. BMJ 2003;327:557</text>
  <text x="473.217" y="575.197" svg_rhmargin="476.953" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="476.959,481.084,485.21" y="575.197" svg_rhmargin="487.227" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">60.</text>
  <text x="345.206,347.612,351.736,355.861,358.267,361.589,366.102,369.838,373.574,376.839,379.716,381.317,388.789,390.388,396.142,399.878,405.631,407.64799999999997,409.266,413.002,416.267,420.392,424.516,427.781,429.799,433.923,437.27,440.147,441.692,449.164,451.181,452.804,460.276,462.294,466.418,470.542,473.808,476.685,478.314,483.679,485.69599999999997,487.271,491.784,493.801,497.537,500.414,502.01,504.027,508.152,509.777,515.919,519.184,521.59,525.326,527.732,531.468,535.592,539.328,541.345,545.081,547.958,549.975,552.852,554.504,558.628,561.894,564.3,567.565,570.83,573.236,576.501,580.626,582.281,586.406" y="584.154" svg_rhmargin="590.142" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[22] Egger M DSG, Schneider M, Minder C. Bias in meta-analysis detected by</text>
  <text x="361.59,365.32599999999996,367.826,370.703,372.72,378.862,382.986,385.004,388.269,390.286,392.826,396.562,399.439,403.175,407.299,411.423,413.441,416.706,420.442,422.459,425.025,427.431,430.696,433.573,435.979,437.996,440.501,445.014,452.486,455.363,457.905,462.029,466.154,470.278,474.402,476.42,480.544,484.669,488.793,490.81,494.935,499.059" y="593.112" svg_rhmargin="503.183" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">a simple, graphical test. BMJ 1997;315:629</text>
  <text x="503.208" y="593.112" svg_rhmargin="506.944" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="506.95,511.076,515.201" y="593.112" svg_rhmargin="517.218" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">34.</text>
  <text svg_rhmargin="458.042" x="345.206,347.612,351.736,355.861,358.267,361.589,367.343,371.467,375.203,378.939,380.956,382.847,386.583,388.6,390.444,395.346,401.099,404.364,407.629,411.754,413.856,417.121,418.959,424.324,426.341,428.2,433.102,435.979,437.996,444.138,446.058,449.794,453.918,458.043" y="602.126" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[23] Duval S, Tweedie R. Trim and </text>
  <text x="459.895" y="602.126" svg_rhmargin="464.019" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="464.034,466.051,468.069,470.086,471.97,475.706,477.526,480.403,482.42,488.562,492.687,494.704,497.969,499.862,502.268,506.392,510.517,514.714,517.979,519.997,522.403,526.527,528.545,532.669,535.075,537.481,541.605,545.341,548.218,551.483,555.608,557.514,563.656,566.921,569.327,573.451,577.576,581.701,583.59,587.715" y="602.126" svg_rhmargin="590.121" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ll: a simple funnel-plot-based method of</text>
  <text x="361.59,363.996,367.261,370.138,372.544,374.561,378.686,382.42199999999997,385.4,389.136,393.26,397.385,400.252,403.988,408.113,410.13,414.254,417.202,419.608,421.625,425.75,429.486,432.395,434.801,438.926,441.803,444.697,448.821,452.946,457.07,459.087,461.105,464.37,468.106,470.512,472.529,476.654,480.779,483.755,487.879,489.897,493.632,496.509,499.401,501.418,505.543,508.471,514.613,517.879,520.284,524.02,526.426,530.162,534.287,538.023,540.04,543.776,546.653,548.777,551.653,553.6700000000001,556.544,561.057,563.074,567.199,573.34,576.606,579.012,581.888,583.906,587.269" y="611.083" svg_rhmargin="590.146" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">testing and adjusting for publication bias in meta-analysis. Biometrics</text>
  <text x="361.587,365.712,369.836,373.961,378.085,380.102,384.227,388.351,390.441,394.566,398.69" y="620.057" svg_rhmargin="402.814" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2000;56:455</text>
  <text x="402.802" y="620.057" svg_rhmargin="406.538" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="406.544,410.67,414.795" y="620.057" svg_rhmargin="416.812" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">63.</text>
  <text x="345.203,347.609,351.733,355.858,358.264,361.587,365.711,369.835,372.712,376.448,379.713,382.119,383.752,387.876,389.893,391.518,398.99,402.725,405.991,410.115,412.209,415.474,417.491,420.368,421.959,424.836,428.96,430.977,432.617,437.982,442.106,446.231,448.248,450.266,453.531,455.179,459.303,465.057,467.074,468.728,471.993,474.399,475.984,479.72,481.737,483.754,485.395,491.537,494.802,498.926,501.332,504.209,508.41,512.535,516.659,518.677,520.694,522.711,524.729,528.465,534.606,538.731,542.855,546.98,550.245,553.981,556.387,559.6519999999999,561.357,564.234,567.97,570.376,572.393,576.518,578.137,581.873,585.998" y="629.014" svg_rhmargin="590.122" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[24] Forget P, Machiels JP, Coulie PG, et al. Neutrophil:lymphocyte ratio and</text>
  <text x="361.587,363.605,367.729,370.135,373.012,376.748,380.872,384.996,388.344,391.22,394.956,397.362,399.38,403.116,406.381,409.262,413.386,416.263,419.52799999999996,422.47,426.596,429.002,431.882,436.006,439.271,441.677,445.802,448.678,452.803,454.82,458.556,461.82099999999997,464.761,468.885,471.762,474.682,478.806,480.824,484.089,486.106,490.231,492.636,495.902,500.026,503.762,507.027,509.942,513.678,516.554,519.819,522.754,526.878,529.755,533.879,537.615,541.74,545.864,548.741,551.147,553.164,556.429,559.375,561.781,565.517,568.782,571.188,575.312,578.189,581.0659999999999,583.978,585.995" y="637.971" svg_rhmargin="590.119" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">intraoperative use of ketorolac or diclofenac are prognostic factors in</text>
  <text x="361.587,365.712,367.729,370.135,372.541,375.806,378.683,381.948,386.072,388.478,390.611,393.877,398.001,402.125,406.25,409.127,411.532,414.409,416.518,420.643,423.049,425.079,429.203,432.939,435.345,437.437,440.702,444.827,447.233,450.11,452.176,456.3,460.425,464.549,467.814,470.691,474.427,478.551,480.569,484.693,488.429,490.497,494.622,497.499,500.764,504.5,507.448,509.854,511.871,513.91,515.928,520.052,524.176,527.912,529.9290000000001,532.05,535.787,539.911,544.036,546.11,550.234,552.252,556.376,560.501,563.766,567.502,569.579,572.844,576.58,580.704,583.97,587.235" y="646.928" svg_rhmargin="590.112" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">different cohorts of patients undergoing breast, lung, and kidney cancer</text>
  <text x="361.587,364.464,368.588,371.465,375.201,378.466,381.343,385.079,387.096,389.648,395.012,399.137,403.262,405.747,409.483,413.607,416.484,420.21999999999997,422.754,428.895,433.02,436.285,440.409,442.426,444.975,449.1,453.224,457.349,461.473,463.491,467.615,471.739,473.757,477.493,481.617,485.742" y="655.942" svg_rhmargin="489.866" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">surgery. Ann Surg Oncol 2013;20:S650</text>
  <text x="489.883" y="655.942" svg_rhmargin="493.619" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="493.624,497.75,501.875" y="655.942" svg_rhmargin="503.892" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">60.</text>
  <text x="345.203,347.609,351.733,355.858,358.264,361.587,367.728,371.853,375.978,377.516,383.74,385.17,389.683,397.154,399.171,400.702,406.926,410.662,414.787,416.291,421.657,423.674,425.136,430.501,433.378,436.643,439.049,443.173,445.191,449.399,452.664,455.541,458.418,459.886,464.011,466.41700000000003,467.936,472.061,474.937,478.202,480.608,483.485,486.75,490.486,492.892,499.034,502.299,506.423,508.829,510.339,514.463,517.728,521.853,524.259,527.135,531.26,535.384,539.59,541.607,543.624,545.089,547.495,551.62,553.14,555.157,558.893,565.035,569.159,573.284,577.408,580.673,584.409,586.815" y="664.899" svg_rhmargin="590.08" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[25] Noh H EM, Han A. Usefulness of pretreatment neutrophil to lymphocyte</text>
  <text x="361.587,364.464,368.2,370.606,372.623,376.748,379.728,381.745,385.87,388.799,392.923,395.8,399.065,403.254,405.272,408.537,410.943,412.96,417.085,420.82099999999997,423.776,427.9,429.918,432.794,436.059,439.795,442.672,445.937,448.343,451.22,455.344,458.609,461.874" y="673.857" svg_rhmargin="463.891" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ratio in predicting disease-speci</text>
  <text x="463.974" y="673.857" svg_rhmargin="468.098" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="468.113,471.378,474.349,477.225,481.35,484.226,487.962,489.98,493.716,497.452,499.469,502.409,504.426,508.551,511.537,515.662,518.538,521.804,525.54,528.416,530.822,533.759,537.025,540.76,544.885,548.215,551.48,554.357,557.286,561.41,565.146,567.552,569.57,572.835,576.959,579.365,582.242,584.259,587.274" y="673.857" svg_rhmargin="590.151" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">c survival in breast cancer patients. J</text>
  <text x="361.587,366.1,368.977,372.242,376.043,378.92,381.326,383.81,389.175,392.911,397.035,400.3,403.565,406.442,408.979,413.104,417.228,421.353,425.477,427.494,431.619,435.743,437.761,441.885" y="682.814" svg_rhmargin="446.009" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Breast Cancer 2013;16:55</text>
  <text x="446.059" y="682.814" svg_rhmargin="449.795" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="449.801,453.926" y="682.814" svg_rhmargin="455.943" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="345.203,347.609,351.733,355.858,358.264,361.587,367.728,371.464,375.589,379.325,383.449,387.574,390.101,395.466,397.483,399.965,406.189,410.314,413.19,417.315,421.439,425.175,427.686,435.158,437.175,439.648,445.014,448.749,454.891,458.627,464.769,468.893,471.299,475.424,477.913,485.385,487.402,489.875,493.14,495.546,498.039,501.775,503.792,505.80899999999997,508.3,512.424,515.301,519.425,523.161,527.286,531.41,534.287,536.693,538.797,542.062,544.523,547.4,549.417,553.153,557.277" y="691.771" svg_rhmargin="559.294" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[26] Nakano K, Hosoda M, Yamamoto M, et al. Prognostic signi</text>
  <text x="559.331" y="691.771" svg_rhmargin="563.455" style="fill:#171615;font-family:MMHCMO+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="563.469,566.735,570.47,574.595,577.86,581.125,583.594,587.718" y="691.771" svg_rhmargin="590.124" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cance of</text>
  <text x="361.587,365.712,368.588,371.854,374.259,376.665,379.542,382.807,386.543,388.949,395.204,398.469,402.593,404.999,408.412,412.537,415.802,419.926,422.332,425.209,429.333,433.458,437.664,439.681,441.698,443.715,447.188,449.205,452.941,459.083,463.207,467.332,471.456,474.721,478.457,480.863,484.128,487.607,490.483,494.219,496.625,498.642,502.767,506.258,508.275,512.4,515.839,518.715,522.451,526.576,530.312,534.436,537.701,540.578,543.843,547.358,551.482,555.218,557.624,559.641,562.907,567.031,569.437,572.314,575.816,581.569,583.586,585.992" y="700.728" svg_rhmargin="590.116" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">pre-treatment neutrophil: lymphocyte ratio in Japanese patients with</text>
  <text x="361.587,365.712,368.588,371.854,375.589,378.466,380.872,383.412,386.678,390.413,394.538,397.803,401.068,403.945,405.962,408.468,413.833,417.957,420.363,422.381,425.646,429.382,433.506,436.869,440.134,443.011,445.486,450.851,454.116,456.993,459.545,463.669,467.794,471.918,476.042,478.06,482.184,486.309,488.326,492.45,496.575,500.699" y="709.742" svg_rhmargin="504.823" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">breast cancer. Anticancer Res 2014;34:3819</text>
  <text x="504.849" y="709.742" svg_rhmargin="508.585" style="fill:#171615;font-family:MMHCMP+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="508.591,512.716,516.84" y="709.742" svg_rhmargin="518.857" style="fill:#171615;font-family:MMHCMN+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">24.</text>
  <text x="85.039,90.435,94.667,98.732,102.964,105.562,109.627,111.946,114.633,118.698,120.108,122.26,124.894,131.445,135.51,140.069,141.48,145.544,146.955,151.187,155.252,157.831,159.736,164.136,168.535,172.935,177.334,179.239,181.868,186.267,190.667,192.819,197.218,201.617,517.041,522.931,528.821,534.711,536.863,543.414,547.973,550.874,552.285,556.685,560.917,563.3,567.532,571.597,573.008,575.16,579.224,583.624" y="9.870999999999981" svg_rhmargin="590.176" style="fill:#171615;font-family:MMHCLI+AdvOT6e5d2ec0;font-size:7.97px;font-style:NORMAL;font-weight:normal;">Duan et al. Medicine (2018) 97:49 www.md-journal.com</text>
  <text x="335.396" y="739.625" svg_rhmargin="339.796" style="fill:#171615;font-family:MMHDEE+AdvOTf94803d4;font-size:7.97px;font-style:NORMAL;font-weight:normal;">9</text>
 </g>
</svg>
